{
    "abstract": "A variety of Good Manufacturing Practice (GMP) compliant processes have been reported for production of non-replicating adenovirus vectors, but important challenges remain. Most clinical development of adenovirus vectors now uses simian adenoviruses or rare human serotypes, whereas reported manufacturing processes mainly use serotypes such as AdHu5 which are of questionable relevance for clinical vaccine development. Many clinically relevant vaccine transgenes interfere with adenovirus replication, whereas most reported process development uses selected antigens or even model transgenes such as fluorescent proteins which cause little such interference. Processes are typically developed for a single adenovirus serotype \u2013 transgene combination, requiring extensive further optimization for each new vaccine. There is a need for rapid production platforms for small GMP batches of non-replicating adenovirus vectors for early-phase vaccine trials, particularly in preparation for response to emerging pathogen outbreaks. Such platforms must be robust to variation in the transgene, and ideally also capable of producing adenoviruses of more than one serotype. It is also highly desirable for such processes to be readily implemented in new facilities using commercially available single-use materials, avoiding the need for development of bespoke tools or cleaning validation, and for them to be readily scalable for later-stage studies. Here we report the development of such a process, using single-use stirred-tank bioreactors, a transgene-repressing HEK293 cell \u2013 promoter combination, and fully single-use filtration and ion exchange components. We demonstrate applicability of the process to candidate vaccines against rabies, malaria and Rift Valley fever, each based on a different adenovirus serotype. We compare performance of a range of commercially available ion exchange media, including what we believe to be the first published use of a novel media for adenovirus purification (NatriFlo\u00ae HD-Q, Merck). We demonstrate the need for minimal process individualization for each vaccine, and that the product fulfils regulatory quality expectations. Cell-specific yields are at the upper end of those previously reported in the literature, and volumetric yields are in the range 1 \u00d7 1013 \u2013 5 \u00d7 1013 purified virus particles per litre of culture, such that a 2\u20134 L process is comfortably adequate to produce vaccine for early-phase trials. The process is readily transferable to any GMP facility with the capability for mammalian cell culture and aseptic filling of sterile products.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "George M.",
                    "initial": "G.M.",
                    "last": "Warimwe"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.04.085",
            "firstpage": "4461",
            "issn": "0264410X",
            "lastpage": "4464",
            "pmid": "28576573",
            "pub_year": 2017,
            "title": "Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology",
            "volume": "35"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                },
                {
                    "first": "Christine S.",
                    "initial": "C.S.",
                    "last": "Rollier"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Dorrell"
                }
            ],
            "doi": "10.1016/j.coi.2016.05.014",
            "firstpage": "47",
            "issn": "09527915",
            "lastpage": "54",
            "pmid": "27286566",
            "pub_year": 2016,
            "title": "Viral vectors as vaccine platforms: From immunogenicity to impact",
            "volume": "41"
        },
        "b0015": null,
        "b0020": {
            "authors": [
                {
                    "first": "Jort",
                    "initial": "J.",
                    "last": "Vellinga"
                },
                {
                    "first": "J. Patrick",
                    "initial": "J.P.",
                    "last": "Smith"
                },
                {
                    "first": "Agnieszka",
                    "initial": "A.",
                    "last": "Lipiec"
                },
                {
                    "first": "Dragomira",
                    "initial": "D.",
                    "last": "Majhen"
                },
                {
                    "first": "Angelique",
                    "initial": "A.",
                    "last": "Lemckert"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Van Ooij"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Ives"
                },
                {
                    "first": "Christopher",
                    "initial": "C.",
                    "last": "Yallop"
                },
                {
                    "first": "Jerome",
                    "initial": "J.",
                    "last": "Custers"
                },
                {
                    "first": "Menzo",
                    "initial": "M.",
                    "last": "Havenga"
                }
            ],
            "doi": "10.1089/hum.2014.007",
            "firstpage": "318",
            "issn": "10430342",
            "lastpage": "327",
            "pmid": "24593243",
            "pub_year": 2014,
            "title": "Challenges in manufacturing adenoviral vectors for global vaccine product deployment",
            "volume": "25"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Muhammed O.",
                    "initial": "M.O.",
                    "last": "Afolabi"
                },
                {
                    "first": "Alfred B.",
                    "initial": "A.B.",
                    "last": "Tiono"
                },
                {
                    "first": "Uche J.",
                    "initial": "U.J.",
                    "last": "Adetifa"
                },
                {
                    "first": "Jean Baptiste",
                    "initial": "J.B.",
                    "last": "Yaro"
                },
                {
                    "first": "Abdoulie",
                    "initial": "A.",
                    "last": "Drammeh"
                },
                {
                    "first": "Issa",
                    "initial": "I.",
                    "last": "N\u00e9bi\u00e9"
                },
                {
                    "first": "Carly",
                    "initial": "C.",
                    "last": "Bliss"
                },
                {
                    "first": "Susanne H.",
                    "initial": "S.H.",
                    "last": "Hodgson"
                },
                {
                    "first": "Nicholas A.",
                    "initial": "N.A.",
                    "last": "Anagnostou"
                },
                {
                    "first": "Guillaume S.",
                    "initial": "G.S.",
                    "last": "Sanou"
                },
                {
                    "first": "Ya Jankey",
                    "initial": "Y.J.",
                    "last": "Jagne"
                },
                {
                    "first": "Oumarou",
                    "initial": "O.",
                    "last": "Ouedraogo"
                },
                {
                    "first": "Casimir",
                    "initial": "C.",
                    "last": "Tamara"
                },
                {
                    "first": "Nicolas",
                    "initial": "N.",
                    "last": "Ouedraogo"
                },
                {
                    "first": "Mirielle",
                    "initial": "M.",
                    "last": "Ouedraogo"
                },
                {
                    "first": "Jainaba",
                    "initial": "J.",
                    "last": "Njie-Jobe"
                },
                {
                    "first": "Amidou",
                    "initial": "A.",
                    "last": "Diarra"
                },
                {
                    "first": "Christopher J.A.",
                    "initial": "C.J.A.",
                    "last": "Duncan"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Roberts"
                },
                {
                    "first": "Nicola K.",
                    "initial": "N.K.",
                    "last": "Viebig"
                },
                {
                    "first": "Odile",
                    "initial": "O.",
                    "last": "Leroy"
                },
                {
                    "first": "Alison M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "Katie L.",
                    "initial": "K.L.",
                    "last": "Flanagan"
                },
                {
                    "first": "Beate",
                    "initial": "B.",
                    "last": "Kampman"
                },
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Bejon"
                },
                {
                    "first": "Egeruan B.",
                    "initial": "E.B.",
                    "last": "Imoukhuede"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Kalifa",
                    "initial": "K.",
                    "last": "Bojang"
                },
                {
                    "first": "Sodiomon B.",
                    "initial": "S.B.",
                    "last": "Sirima"
                }
            ],
            "doi": "10.1038/mt.2016.83",
            "firstpage": "1470",
            "issn": "15250016",
            "lastpage": "1477",
            "pmid": "27109630",
            "pub_year": 2016,
            "title": "Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants",
            "volume": "24"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Ogwang"
                },
                {
                    "first": "Muhammed",
                    "initial": "M.",
                    "last": "Afolabi"
                },
                {
                    "first": "Domtila",
                    "initial": "D.",
                    "last": "Kimani"
                },
                {
                    "first": "Ya Jankey",
                    "initial": "Y.J.",
                    "last": "Jagne"
                },
                {
                    "first": "Susanne H.",
                    "initial": "S.H.",
                    "last": "Sheehy"
                },
                {
                    "first": "Carly M.",
                    "initial": "C.M.",
                    "last": "Bliss"
                },
                {
                    "first": "Christopher J.A.",
                    "initial": "C.J.A.",
                    "last": "Duncan"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Miguel A.",
                    "initial": "M.A.",
                    "last": "Garcia Knight"
                },
                {
                    "first": "Eva",
                    "initial": "E.",
                    "last": "Kimani"
                },
                {
                    "first": "Nicholas A.",
                    "initial": "N.A.",
                    "last": "Anagnostou"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Moyle"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Peninah",
                    "initial": "P.",
                    "last": "Soipei"
                },
                {
                    "first": "Jenny",
                    "initial": "J.",
                    "last": "Mueller"
                },
                {
                    "first": "Joseph",
                    "initial": "J.",
                    "last": "Okebe"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Nicola K.",
                    "initial": "N.K.",
                    "last": "Viebig"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Roberts"
                },
                {
                    "first": "Katherine",
                    "initial": "K.",
                    "last": "Gantlett"
                },
                {
                    "first": "Alison M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Egeruan B.",
                    "initial": "E.B.",
                    "last": "Imoukhuede"
                },
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Bejon"
                },
                {
                    "first": "Britta C.",
                    "initial": "B.C.",
                    "last": "Urban"
                },
                {
                    "first": "Katie L.",
                    "initial": "K.L.",
                    "last": "Flanagan"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Roma",
                    "initial": "R.",
                    "last": "Chilengi"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Kalifa",
                    "initial": "K.",
                    "last": "Bojang"
                }
            ],
            "doi": "10.1371/journal.pone.0057726",
            "issn": "19326203",
            "pmid": "23526949",
            "pub_year": 2013,
            "title": "Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults",
            "volume": "8"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Lindsey R.",
                    "initial": "L.R.",
                    "last": "Baden"
                },
                {
                    "first": "Stephen R.",
                    "initial": "S.R.",
                    "last": "Walsh"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Seaman"
                },
                {
                    "first": "Robert P.",
                    "initial": "R.P.",
                    "last": "Tucker"
                },
                {
                    "first": "Kathleen H.",
                    "initial": "K.H.",
                    "last": "Krause"
                },
                {
                    "first": "Alka",
                    "initial": "A.",
                    "last": "Patel"
                },
                {
                    "first": "Jennifer A.",
                    "initial": "J.A.",
                    "last": "Johnson"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Kleinjan"
                },
                {
                    "first": "Katherine E.",
                    "initial": "K.E.",
                    "last": "Yanosick"
                },
                {
                    "first": "James",
                    "initial": "J.",
                    "last": "Perry"
                },
                {
                    "first": "Elise",
                    "initial": "E.",
                    "last": "Zablowsky"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Abbink"
                },
                {
                    "first": "Lauren",
                    "initial": "L.",
                    "last": "Peter"
                },
                {
                    "first": "M. Justin",
                    "initial": "M.J.",
                    "last": "Iampietro"
                },
                {
                    "first": "Ann",
                    "initial": "A.",
                    "last": "Cheung"
                },
                {
                    "first": "Maria G.",
                    "initial": "M.G.",
                    "last": "Pau"
                },
                {
                    "first": "Mo",
                    "initial": "M.",
                    "last": "Weijtens"
                },
                {
                    "first": "Jaap",
                    "initial": "J.",
                    "last": "Goudsmit"
                },
                {
                    "first": "Edith",
                    "initial": "E.",
                    "last": "Swann"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Wolff"
                },
                {
                    "first": "Hayley",
                    "initial": "H.",
                    "last": "Loblein"
                },
                {
                    "first": "Raphael",
                    "initial": "R.",
                    "last": "Dolin"
                },
                {
                    "first": "Dan H.",
                    "initial": "D.H.",
                    "last": "Barouch"
                }
            ],
            "doi": "10.1093/infdis/jis670",
            "firstpage": "240",
            "issn": "00221899",
            "lastpage": "247",
            "pmid": "23125444",
            "pub_year": 2013,
            "title": "First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)",
            "volume": "207"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Dan H.",
                    "initial": "D.H.",
                    "last": "Barouch"
                },
                {
                    "first": "Sandra V.",
                    "initial": "S.V.",
                    "last": "Kik"
                },
                {
                    "first": "Gerrit J.",
                    "initial": "G.J.",
                    "last": "Weverling"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Dilan"
                },
                {
                    "first": "Sharon L.",
                    "initial": "S.L.",
                    "last": "King"
                },
                {
                    "first": "Lori F.",
                    "initial": "L.F.",
                    "last": "Maxfield"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Clark"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Ng'ang'a"
                },
                {
                    "first": "Kara L.",
                    "initial": "K.L.",
                    "last": "Brandariz"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Abbink"
                },
                {
                    "first": "Faruk",
                    "initial": "F.",
                    "last": "Sinangil"
                },
                {
                    "first": "Guy",
                    "initial": "G.",
                    "last": "de Bruyn"
                },
                {
                    "first": "Glenda E.",
                    "initial": "G.E.",
                    "last": "Gray"
                },
                {
                    "first": "Surita",
                    "initial": "S.",
                    "last": "Roux"
                },
                {
                    "first": "Linda Gail",
                    "initial": "L.G.",
                    "last": "Bekker"
                },
                {
                    "first": "Athmanundh",
                    "initial": "A.",
                    "last": "Dilraj"
                },
                {
                    "first": "Hannah",
                    "initial": "H.",
                    "last": "Kibuuka"
                },
                {
                    "first": "Merlin L.",
                    "initial": "M.L.",
                    "last": "Robb"
                },
                {
                    "first": "Nelson L.",
                    "initial": "N.L.",
                    "last": "Michael"
                },
                {
                    "first": "Omu",
                    "initial": "O.",
                    "last": "Anzala"
                },
                {
                    "first": "Pauli N.",
                    "initial": "P.N.",
                    "last": "Amornkul"
                },
                {
                    "first": "Jill",
                    "initial": "J.",
                    "last": "Gilmour"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "Hural"
                },
                {
                    "first": "Susan P.",
                    "initial": "S.P.",
                    "last": "Buchbinder"
                },
                {
                    "first": "Michael S.",
                    "initial": "M.S.",
                    "last": "Seaman"
                },
                {
                    "first": "Raphael",
                    "initial": "R.",
                    "last": "Dolin"
                },
                {
                    "first": "Lindsey R.",
                    "initial": "L.R.",
                    "last": "Baden"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Carville"
                },
                {
                    "first": "Keith G.",
                    "initial": "K.G.",
                    "last": "Mansfield"
                },
                {
                    "first": "Maria G.",
                    "initial": "M.G.",
                    "last": "Pau"
                },
                {
                    "first": "Jaap",
                    "initial": "J.",
                    "last": "Goudsmit"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.05.025",
            "firstpage": "5203",
            "issn": "0264410X",
            "lastpage": "5209",
            "pmid": "21619905",
            "pub_year": 2011,
            "title": "International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations",
            "volume": "29"
        },
        "b0045": null,
        "b0050": {
            "authors": [
                {
                    "first": "Katie",
                    "initial": "K.",
                    "last": "Ewer"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Sebastian"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Teresa",
                    "initial": "T.",
                    "last": "Lambe"
                }
            ],
            "doi": "10.1080/21645515.2017.1383575",
            "firstpage": "3020",
            "issn": "21645515",
            "lastpage": "3032",
            "pmid": "29083948",
            "pub_year": 2017,
            "title": "Chimpanzee adenoviral vectors as vaccines for outbreak pathogens",
            "volume": "13"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Nadeau"
                },
                {
                    "first": "Amine",
                    "initial": "A.",
                    "last": "Kamen"
                }
            ],
            "doi": "10.1016/S0734-9750(02)00030-7",
            "firstpage": "475",
            "issn": "07349750",
            "lastpage": "489",
            "pmid": "14550017",
            "pub_year": 2003,
            "title": "Production of adenovirus vector for gene therapy",
            "volume": "20"
        },
        "b0060": null,
        "b0065": {
            "authors": [
                {
                    "first": "Amine",
                    "initial": "A.",
                    "last": "Kamen"
                },
                {
                    "first": "Olivier",
                    "initial": "O.",
                    "last": "Henry"
                }
            ],
            "doi": "10.1002/jgm.503",
            "firstpage": "S184",
            "issn": "1099498X",
            "lastpage": "S192",
            "pmid": "14978761",
            "pub_year": 2004,
            "title": "Development and optimization of an adenovirus production process",
            "volume": "6"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Anthony P.",
                    "initial": "A.P.",
                    "last": "Green"
                },
                {
                    "first": "James J.",
                    "initial": "J.J.",
                    "last": "Huang"
                },
                {
                    "first": "Miller O.",
                    "initial": "M.O.",
                    "last": "Scott"
                },
                {
                    "first": "Timothy D.",
                    "initial": "T.D.",
                    "last": "Kierstead"
                },
                {
                    "first": "Irene",
                    "initial": "I.",
                    "last": "Beaupr\u00e9"
                },
                {
                    "first": "Guang Ping",
                    "initial": "G.P.",
                    "last": "Gao"
                },
                {
                    "first": "James M.",
                    "initial": "J.M.",
                    "last": "Wilson"
                }
            ],
            "doi": "10.1089/10430340260355338",
            "firstpage": "1921",
            "issn": "10430342",
            "lastpage": "1934",
            "pmid": "12427304",
            "pub_year": 2002,
            "title": "A new scalable method for the purification of recombinant adenovirus vectors",
            "volume": "13"
        },
        "b0075": {
            "authors": [
                {
                    "first": "John O.",
                    "initial": "J.O.",
                    "last": "Konz"
                },
                {
                    "first": "Lee R.",
                    "initial": "L.R.",
                    "last": "Pitts"
                },
                {
                    "first": "Sangeetha L.",
                    "initial": "S.L.",
                    "last": "Sagar"
                }
            ],
            "doi": "10.1007/978-1-60327-248-3_2",
            "firstpage": "13",
            "issn": "10643745",
            "lastpage": "23",
            "pmid": "18470636",
            "pub_year": 2008,
            "title": "Scaleable purification of adenovirus vectors",
            "volume": "434"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Piergiuseppe",
                    "initial": "P.",
                    "last": "Nestola"
                },
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Peixoto"
                },
                {
                    "first": "Louis",
                    "initial": "L.",
                    "last": "Villain"
                },
                {
                    "first": "Paula M.",
                    "initial": "P.M.",
                    "last": "Alves"
                },
                {
                    "first": "Manuel J.T.",
                    "initial": "M.J.T.",
                    "last": "Carrondo"
                },
                {
                    "first": "Jos\u00e9 P.B.",
                    "initial": "J.P.B.",
                    "last": "Mota"
                }
            ],
            "doi": "10.1016/j.chroma.2015.11.037",
            "firstpage": "91",
            "issn": "00219673",
            "lastpage": "101",
            "pmid": "26643723",
            "pub_year": 2015,
            "title": "Rational development of two flowthrough purification strategies for adenovirus type 5 and retro virus-like particles",
            "volume": "1426"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Riske"
                },
                {
                    "first": "Nicole",
                    "initial": "N.",
                    "last": "Berard"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Albee"
                },
                {
                    "first": "Peng",
                    "initial": "P.",
                    "last": "Pan"
                },
                {
                    "first": "Mike",
                    "initial": "M.",
                    "last": "Henderson"
                },
                {
                    "first": "Kris",
                    "initial": "K.",
                    "last": "Adams"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Godwin"
                },
                {
                    "first": "Sherri",
                    "initial": "S.",
                    "last": "Spear"
                }
            ],
            "doi": "10.1002/bit.24742",
            "firstpage": "848",
            "issn": "00063592",
            "lastpage": "856",
            "pmid": "23042531",
            "pub_year": 2013,
            "title": "Development of a platform process for adenovirus purification that removes human set and nucleolin and provides high purity vector for gene delivery",
            "volume": "110"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Cristina",
                    "initial": "C.",
                    "last": "Peixoto"
                },
                {
                    "first": "Tiago B.",
                    "initial": "T.B.",
                    "last": "Ferreira"
                },
                {
                    "first": "Marcos F.Q.",
                    "initial": "M.F.Q.",
                    "last": "Sousa"
                },
                {
                    "first": "Manuel J.T.",
                    "initial": "M.J.T.",
                    "last": "Carrondo"
                },
                {
                    "first": "Paula M.",
                    "initial": "P.M.",
                    "last": "Alves"
                }
            ],
            "doi": "10.1002/btpr.25",
            "firstpage": "1290",
            "issn": "87567938",
            "lastpage": "1296",
            "pmid": "19194943",
            "pub_year": 2008,
            "title": "Towards purification of adenoviral vectors based on membrane technology",
            "volume": "24"
        },
        "b0095": {
            "authors": [
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Fernandes"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Peixoto"
                },
                {
                    "first": "V. M.",
                    "initial": "V.M.",
                    "last": "Santiago"
                },
                {
                    "first": "E. J.",
                    "initial": "E.J.",
                    "last": "Kremer"
                },
                {
                    "first": "A. S.",
                    "initial": "A.S.",
                    "last": "Coroadinha"
                },
                {
                    "first": "P. M.",
                    "initial": "P.M.",
                    "last": "Alves"
                }
            ],
            "doi": "10.1038/gt.2012.52",
            "firstpage": "353",
            "issn": "09697128",
            "lastpage": "360",
            "pmid": "22763405",
            "pub_year": 2013,
            "title": "Bioprocess development for canine adenovirus type 2 vectors",
            "volume": "20"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Matthew G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                },
                {
                    "first": "Fionnadh",
                    "initial": "F.",
                    "last": "Carroll"
                },
                {
                    "first": "Susan J.",
                    "initial": "S.J.",
                    "last": "Morris"
                },
                {
                    "first": "Alison V.",
                    "initial": "A.V.",
                    "last": "Turner"
                },
                {
                    "first": "Aisling M.",
                    "initial": "A.M.",
                    "last": "Vaughan"
                },
                {
                    "first": "Melissa C.",
                    "initial": "M.C.",
                    "last": "Kapulu"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Loredana",
                    "initial": "L.",
                    "last": "Siani"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1002/bit.24342",
            "firstpage": "719",
            "issn": "00063592",
            "lastpage": "728",
            "pmid": "22252512",
            "pub_year": 2012,
            "title": "Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors",
            "volume": "109"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Richard J.",
                    "initial": "R.J.",
                    "last": "Stanton"
                },
                {
                    "first": "Brian P.",
                    "initial": "B.P.",
                    "last": "McSharry"
                },
                {
                    "first": "Melanie",
                    "initial": "M.",
                    "last": "Armstrong"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Tomasec"
                },
                {
                    "first": "Gavin W.G.",
                    "initial": "G.W.G.",
                    "last": "Wilkinson"
                }
            ],
            "doi": "10.2144/000112993",
            "firstpage": "659",
            "issn": "07366205",
            "lastpage": "668",
            "pmid": "19238796",
            "pub_year": 2008,
            "title": "Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function",
            "volume": "45"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Chuan",
                    "initial": "C.",
                    "last": "Wang"
                },
                {
                    "first": "Pawan",
                    "initial": "P.",
                    "last": "Dulal"
                },
                {
                    "first": "Xiangyang",
                    "initial": "X.",
                    "last": "Zhou"
                },
                {
                    "first": "Zhiquan",
                    "initial": "Z.",
                    "last": "Xiang"
                },
                {
                    "first": "Hooman",
                    "initial": "H.",
                    "last": "Goharriz"
                },
                {
                    "first": "Ashley",
                    "initial": "A.",
                    "last": "Banyard"
                },
                {
                    "first": "Nicky",
                    "initial": "N.",
                    "last": "Green"
                },
                {
                    "first": "Livia",
                    "initial": "L.",
                    "last": "Brunner"
                },
                {
                    "first": "Roland",
                    "initial": "R.",
                    "last": "Ventura"
                },
                {
                    "first": "Nicolas",
                    "initial": "N.",
                    "last": "Collin"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Ashfield"
                },
                {
                    "first": "Anthony R.",
                    "initial": "A.R.",
                    "last": "Fooks"
                },
                {
                    "first": "Hildegund C.",
                    "initial": "H.C.",
                    "last": "Ertl"
                },
                {
                    "first": "Alexander D.",
                    "initial": "A.D.",
                    "last": "Douglas"
                }
            ],
            "doi": "10.1371/journal.pntd.0006870",
            "issn": "19352727",
            "pmid": "30372438",
            "pub_year": 2018,
            "title": "A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis",
            "volume": "12"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Arturo",
                    "initial": "A.",
                    "last": "Reyes-Sandoval"
                },
                {
                    "first": "Tamara",
                    "initial": "T.",
                    "last": "Berthoud"
                },
                {
                    "first": "Nicola",
                    "initial": "N.",
                    "last": "Alder"
                },
                {
                    "first": "Loredana",
                    "initial": "L.",
                    "last": "Siani"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1128/IAI.00740-09",
            "firstpage": "145",
            "issn": "00199567",
            "lastpage": "153",
            "pmid": "19858306",
            "pub_year": 2010,
            "title": "Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses",
            "volume": "78"
        },
        "b0120": {
            "authors": [
                {
                    "first": "George M.",
                    "initial": "G.M.",
                    "last": "Warimwe"
                },
                {
                    "first": "Gema",
                    "initial": "G.",
                    "last": "Lorenzo"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Lopez-Gil"
                },
                {
                    "first": "Arturo",
                    "initial": "A.",
                    "last": "Reyes-Sandoval"
                },
                {
                    "first": "Matthew G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Katharine A.",
                    "initial": "K.A.",
                    "last": "Collins"
                },
                {
                    "first": "Matthew Dj",
                    "initial": "M.D.",
                    "last": "Dicks"
                },
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Milicic"
                },
                {
                    "first": "Amar",
                    "initial": "A.",
                    "last": "Lall"
                },
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "Furze"
                },
                {
                    "first": "Alison V.",
                    "initial": "A.V.",
                    "last": "Turner"
                },
                {
                    "first": "Adrian Vs",
                    "initial": "A.V.",
                    "last": "Hill"
                },
                {
                    "first": "Alejandro",
                    "initial": "A.",
                    "last": "Brun"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                }
            ],
            "doi": "10.1186/1743-422X-10-349",
            "issn": "1743422X",
            "pmid": "24304565",
            "pub_year": 2013,
            "title": "Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice",
            "volume": "10"
        },
        "b0125": {
            "authors": [
                {
                    "first": "Matthew D.J.",
                    "initial": "M.D.J.",
                    "last": "Dicks"
                },
                {
                    "first": "Alexandra J.",
                    "initial": "A.J.",
                    "last": "Spencer"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "G\u00f6ran",
                    "initial": "G.",
                    "last": "Wadell"
                },
                {
                    "first": "Kalifa",
                    "initial": "K.",
                    "last": "Bojang"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Matthew G.",
                    "initial": "M.G.",
                    "last": "Cottingham"
                }
            ],
            "doi": "10.1371/journal.pone.0040385",
            "issn": "19326203",
            "pmid": "22808149",
            "pub_year": 2012,
            "title": "A novel chimpanzee adenovirus vector with low human seroprevalence: Improved systems for vector derivation and comparative immunogenicity",
            "volume": "7"
        },
        "b0130": null,
        "b0135": {
            "authors": [
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Barnes"
                },
                {
                    "first": "Antonella",
                    "initial": "A.",
                    "last": "Folgori"
                },
                {
                    "first": "Virginia",
                    "initial": "V.",
                    "last": "Ammendola"
                },
                {
                    "first": "Stefania",
                    "initial": "S.",
                    "last": "Capone"
                },
                {
                    "first": "Agostino",
                    "initial": "A.",
                    "last": "Cirillo"
                },
                {
                    "first": "Loredana",
                    "initial": "L.",
                    "last": "Siani"
                },
                {
                    "first": "Mariarosaria",
                    "initial": "M.",
                    "last": "Naddeo"
                },
                {
                    "first": "Fabiana",
                    "initial": "F.",
                    "last": "Grazioli"
                },
                {
                    "first": "Maria Luisa",
                    "initial": "M.L.",
                    "last": "Esposito"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Ambrosio"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Sparacino"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Bartiromo"
                },
                {
                    "first": "Annalisa",
                    "initial": "A.",
                    "last": "Meola"
                },
                {
                    "first": "Kira",
                    "initial": "K.",
                    "last": "Smith"
                },
                {
                    "first": "Ayako",
                    "initial": "A.",
                    "last": "Kurioka"
                },
                {
                    "first": "Geraldine A.",
                    "initial": "G.A.",
                    "last": "O'Hara"
                },
                {
                    "first": "Katie J.",
                    "initial": "K.J.",
                    "last": "Ewer"
                },
                {
                    "first": "Nicholas",
                    "initial": "N.",
                    "last": "Anagnostou"
                },
                {
                    "first": "Carly",
                    "initial": "C.",
                    "last": "Bliss"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Cinzia",
                    "initial": "C.",
                    "last": "Traboni"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Klenerman"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                }
            ],
            "doi": "10.1126/scitranslmed.3002925",
            "issn": "19466234",
            "pmid": "22218691",
            "pub_year": 2012,
            "title": "Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species",
            "volume": "4"
        },
        "b0140": {
            "authors": [
                {
                    "first": "Jacob V.",
                    "initial": "J.V.",
                    "last": "Maizel"
                },
                {
                    "first": "David O.",
                    "initial": "D.O.",
                    "last": "White"
                },
                {
                    "first": "Matthew D.",
                    "initial": "M.D.",
                    "last": "Scharff"
                }
            ],
            "doi": "10.1016/0042-6822(68)90121-9",
            "firstpage": "115",
            "issn": "00426822",
            "lastpage": "125",
            "pmid": "5669982",
            "pub_year": 1968,
            "title": "The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12",
            "volume": "36"
        },
        "b0145": {
            "authors": [
                {
                    "first": "Eddie",
                    "initial": "E.",
                    "last": "Takahashi"
                },
                {
                    "first": "Steven L.",
                    "initial": "S.L.",
                    "last": "Cohen"
                },
                {
                    "first": "P. K.",
                    "initial": "P.K.",
                    "last": "Tsai"
                },
                {
                    "first": "Joyce A.",
                    "initial": "J.A.",
                    "last": "Sweeney"
                }
            ],
            "doi": "10.1016/j.ab.2005.11.014",
            "firstpage": "208",
            "issn": "00032697",
            "lastpage": "217",
            "pmid": "16360111",
            "pub_year": 2006,
            "title": "Quantitation of adenovirus type 5 empty capsids",
            "volume": "349"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Wei",
                    "initial": "W.",
                    "last": "Zhang"
                },
                {
                    "first": "Meng",
                    "initial": "M.",
                    "last": "Wu"
                },
                {
                    "first": "Emily",
                    "initial": "E.",
                    "last": "Menesale"
                },
                {
                    "first": "Tongjun",
                    "initial": "T.",
                    "last": "Lu"
                },
                {
                    "first": "Aeona",
                    "initial": "A.",
                    "last": "Magliola"
                },
                {
                    "first": "Svetlana",
                    "initial": "S.",
                    "last": "Bergelson"
                }
            ],
            "doi": "10.1016/j.jpba.2014.07.037",
            "firstpage": "145",
            "issn": "07317085",
            "lastpage": "149",
            "pmid": "25165010",
            "pub_year": 2014,
            "title": "Development and qualification of a high sensitivity, high throughput Q-PCR assay for quantitation of residual host cell DNA in purification process intermediate and drug substance samples",
            "volume": "100"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Prescott",
                    "initial": "P.",
                    "last": "Deininger"
                }
            ],
            "doi": "10.1186/gb-2011-12-12-236",
            "issn": "14747596",
            "pmid": "22204421",
            "pub_year": 2011,
            "title": "Alu elements: Know the SINEs",
            "volume": "12"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Alexander D.",
                    "initial": "A.D.",
                    "last": "Douglas"
                },
                {
                    "first": "Andrew R.",
                    "initial": "A.R.",
                    "last": "Williams"
                },
                {
                    "first": "Joseph J.",
                    "initial": "J.J.",
                    "last": "Illingworth"
                },
                {
                    "first": "Gathoni",
                    "initial": "G.",
                    "last": "Kamuyu"
                },
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "Anna L.",
                    "initial": "A.L.",
                    "last": "Goodman"
                },
                {
                    "first": "David H.",
                    "initial": "D.H.",
                    "last": "Wyllie"
                },
                {
                    "first": "C\u00e9cile",
                    "initial": "C.",
                    "last": "Crosnier"
                },
                {
                    "first": "Kazutoyo",
                    "initial": "K.",
                    "last": "Miura"
                },
                {
                    "first": "Gavin J.",
                    "initial": "G.J.",
                    "last": "Wright"
                },
                {
                    "first": "Carole A.",
                    "initial": "C.A.",
                    "last": "Long"
                },
                {
                    "first": "Faith H.",
                    "initial": "F.H.",
                    "last": "Osier"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Marsh"
                },
                {
                    "first": "Alison V.",
                    "initial": "A.V.",
                    "last": "Turner"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.1038/ncomms1615",
            "issn": "20411723",
            "pmid": "22186897",
            "pub_year": 2011,
            "title": "The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody",
            "volume": "2"
        },
        "b0165": {
            "authors": [
                {
                    "first": "Alessandra",
                    "initial": "A.",
                    "last": "Vitelli"
                },
                {
                    "first": "Mary R.",
                    "initial": "M.R.",
                    "last": "Quirion"
                },
                {
                    "first": "Chia Yun",
                    "initial": "C.Y.",
                    "last": "Lo"
                },
                {
                    "first": "Julia A.",
                    "initial": "J.A.",
                    "last": "Misplon"
                },
                {
                    "first": "Agnieszka K.",
                    "initial": "A.K.",
                    "last": "Grabowska"
                },
                {
                    "first": "Angiolo",
                    "initial": "A.",
                    "last": "Pierantoni"
                },
                {
                    "first": "Virginia",
                    "initial": "V.",
                    "last": "Ammendola"
                },
                {
                    "first": "Graeme E.",
                    "initial": "G.E.",
                    "last": "Price"
                },
                {
                    "first": "Mark R.",
                    "initial": "M.R.",
                    "last": "Soboleski"
                },
                {
                    "first": "Riccardo",
                    "initial": "R.",
                    "last": "Cortese"
                },
                {
                    "first": "Stefano",
                    "initial": "S.",
                    "last": "Colloca"
                },
                {
                    "first": "Alfredo",
                    "initial": "A.",
                    "last": "Nicosia"
                },
                {
                    "first": "Suzanne L.",
                    "initial": "S.L.",
                    "last": "Epstein"
                }
            ],
            "doi": "10.1371/journal.pone.0055435",
            "issn": "19326203",
            "pmid": "23536756",
            "pub_year": 2013,
            "title": "Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus",
            "volume": "8"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Ruth O.",
                    "initial": "R.O.",
                    "last": "Payne"
                },
                {
                    "first": "Sarah E.",
                    "initial": "S.E.",
                    "last": "Silk"
                },
                {
                    "first": "Sean C.",
                    "initial": "S.C.",
                    "last": "Elias"
                },
                {
                    "first": "Kazutoyo",
                    "initial": "K.",
                    "last": "Miura"
                },
                {
                    "first": "Ababacar",
                    "initial": "A.",
                    "last": "Diouf"
                },
                {
                    "first": "Francis",
                    "initial": "F.",
                    "last": "Galaway"
                },
                {
                    "first": "Hans",
                    "initial": "H.",
                    "last": "De Graaf"
                },
                {
                    "first": "Nathan J.",
                    "initial": "N.J.",
                    "last": "Brendish"
                },
                {
                    "first": "Ian D.",
                    "initial": "I.D.",
                    "last": "Poulton"
                },
                {
                    "first": "Oliver J.",
                    "initial": "O.J.",
                    "last": "Griffiths"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Edwards"
                },
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Jin"
                },
                {
                    "first": "Genevi\u00e8ve M.",
                    "initial": "G.M.",
                    "last": "Labb\u00e9"
                },
                {
                    "first": "Daniel G.W.",
                    "initial": "D.G.W.",
                    "last": "Alanine"
                },
                {
                    "first": "Loredana",
                    "initial": "L.",
                    "last": "Siani"
                },
                {
                    "first": "Stefania Di",
                    "initial": "S.D.",
                    "last": "Marco"
                },
                {
                    "first": "Rachel",
                    "initial": "R.",
                    "last": "Roberts"
                },
                {
                    "first": "Nicky",
                    "initial": "N.",
                    "last": "Green"
                },
                {
                    "first": "Eleanor",
                    "initial": "E.",
                    "last": "Berrie"
                },
                {
                    "first": "Andrew S.",
                    "initial": "A.S.",
                    "last": "Ishizuka"
                },
                {
                    "first": "Carolyn M.",
                    "initial": "C.M.",
                    "last": "Nielsen"
                },
                {
                    "first": "Martino",
                    "initial": "M.",
                    "last": "Bardelli"
                },
                {
                    "first": "Frederica D.",
                    "initial": "F.D.",
                    "last": "Partey"
                },
                {
                    "first": "Michael F.",
                    "initial": "M.F.",
                    "last": "Ofori"
                },
                {
                    "first": "Lea",
                    "initial": "L.",
                    "last": "Barfod"
                },
                {
                    "first": "Juliana",
                    "initial": "J.",
                    "last": "Wambua"
                },
                {
                    "first": "Linda M.",
                    "initial": "L.M.",
                    "last": "Murungi"
                },
                {
                    "first": "Faith H.",
                    "initial": "F.H.",
                    "last": "Osier"
                },
                {
                    "first": "Sumi",
                    "initial": "S.",
                    "last": "Biswas"
                },
                {
                    "first": "James S.",
                    "initial": "J.S.",
                    "last": "McCarthy"
                },
                {
                    "first": "Angela M.",
                    "initial": "A.M.",
                    "last": "Minassian"
                },
                {
                    "first": "Rebecca",
                    "initial": "R.",
                    "last": "Ashfield"
                },
                {
                    "first": "Nicola K.",
                    "initial": "N.K.",
                    "last": "Viebig"
                },
                {
                    "first": "Fay L.",
                    "initial": "F.L.",
                    "last": "Nugent"
                },
                {
                    "first": "Alexander D.",
                    "initial": "A.D.",
                    "last": "Douglas"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Vekemans"
                },
                {
                    "first": "Gavin J.",
                    "initial": "G.J.",
                    "last": "Wright"
                },
                {
                    "first": "Saul N.",
                    "initial": "S.N.",
                    "last": "Faust"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                },
                {
                    "first": "Carole A.",
                    "initial": "C.A.",
                    "last": "Long"
                },
                {
                    "first": "Alison M.",
                    "initial": "A.M.",
                    "last": "Lawrie"
                },
                {
                    "first": "Simon J.",
                    "initial": "S.J.",
                    "last": "Draper"
                }
            ],
            "doi": "10.1172/jci.insight.96381",
            "issn": "23793708",
            "pmid": "29093263",
            "pub_year": 2017,
            "title": "Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions",
            "volume": "2"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Aaron R.",
                    "initial": "A.R.",
                    "last": "Goerke"
                },
                {
                    "first": "Brian C.S.",
                    "initial": "B.C.S.",
                    "last": "To"
                },
                {
                    "first": "Ann L.",
                    "initial": "A.L.",
                    "last": "Lee"
                },
                {
                    "first": "Sangeetha L.",
                    "initial": "S.L.",
                    "last": "Sagar"
                },
                {
                    "first": "John O.",
                    "initial": "J.O.",
                    "last": "Konz"
                }
            ],
            "doi": "10.1002/bit.20406",
            "firstpage": "12",
            "issn": "00063592",
            "lastpage": "21",
            "pmid": "15889400",
            "pub_year": 2005,
            "title": "Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA",
            "volume": "91"
        },
        "b0180": {
            "authors": [
                {
                    "first": "John O.",
                    "initial": "J.O.",
                    "last": "Konz"
                },
                {
                    "first": "Rebecca C.",
                    "initial": "R.C.",
                    "last": "Livingood"
                },
                {
                    "first": "Andrew J.",
                    "initial": "A.J.",
                    "last": "Bett"
                },
                {
                    "first": "Aaron R.",
                    "initial": "A.R.",
                    "last": "Goerke"
                },
                {
                    "first": "Michael E.",
                    "initial": "M.E.",
                    "last": "Laska"
                },
                {
                    "first": "Sangeetha L.",
                    "initial": "S.L.",
                    "last": "Sagar"
                }
            ],
            "doi": "10.1089/hum.2005.16.1346",
            "firstpage": "1346",
            "issn": "10430342",
            "lastpage": "1353",
            "pmid": "16259569",
            "pub_year": 2005,
            "title": "Serotype specificity of adenovirus purification using anion-exchange chromatography",
            "volume": "16"
        },
        "b0185": null
    },
    "body_text": [
        {
            "endOffset": 35802,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "For ChAdOx2, wash and elution conditions were as described above for small-scale experiments.",
            "startOffset": 35709,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 57977,
            "parents": [],
            "secId": "s0080",
            "sentence": "Ongoing work in our Institute aims to address this issue.",
            "startOffset": 57920,
            "title": "Discussion"
        },
        {
            "endOffset": 31888,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 31848,
                    "startOffset": 31844
                }
            },
            "secId": "s0035",
            "sentence": "Following ion exchange chromatography (IEX), eluate was buffer exchanged with 6\u20138 diavolumes of A438 formulation buffer [27] by means of a second TFF step (\u2018TFF2\u2032).",
            "startOffset": 31724,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 42375,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Notably, ChAd63 infection consistently causes more rapid cell lysis than ChAdOx1 or ChAdOx2- an effect seen here, and also repeatedly in pre-clinical work (Jenner Institute Viral Vector Core Facility, unpublished observations).",
            "startOffset": 42148,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 42147,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "It is important to note that, although repression of transgene expression substantially reduces variability between viruses of a single serotype encoding different antigens, it does not affect the fundamental growth characteristics of the different serotypes.",
            "startOffset": 41888,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 25997,
            "parents": [],
            "secId": "s0005",
            "sentence": "Here, we set out to develop a GMP-suitable process which is sufficiently robust to be used across multiple adenovirus serotypes carrying a variety of pathogen transgenes with minimal product-specific process development.",
            "startOffset": 25777,
            "title": "Introduction"
        },
        {
            "endOffset": 33117,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Buffers used were \u2018loading buffer\u2019 (as described above) and \u2018Buffer B\u2019 (1 M NaCl, 1 mM MgCl2, 0.1% v/v polysorbate 20, 5% w/v sucrose, 50 mM trisHCl, pH 8.0).",
            "startOffset": 32959,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 57705,
            "parents": [],
            "secId": "s0080",
            "sentence": "It is likely that conditions pre-established to be suitable for a given serotype (i.e. for ChAdOx2, ChAdOx1 and ChAd63, those conditions used here) will be applicable regardless of the transgene- and hence even those simple optimization experiments may not be necessary to assure satisfactory yields for early-phase clinical trials.",
            "startOffset": 57373,
            "title": "Discussion"
        },
        {
            "endOffset": 28591,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "For small-scale upstream process experiments (virus growth kinetics, Fig. 1), 15 mL of culture at the specified density was inoculated at the specified multiplicity of infection (MOI) in an Erlenmeyer flask; 3 h later, a feed of 1.5 volumes of fresh complete medium was added.",
            "startOffset": 28315,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 41623,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Yields were similar at cell densities of 2.0 \u00d7 106 cells/mL during infection (data not shown).",
            "startOffset": 41529,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 31523,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 31522,
                    "startOffset": 31518
                }
            },
            "secId": "s0035",
            "sentence": "Where conversion rates (permeate flow as proportion of feed flow) exceeded 20%, a third pump was used for permeate control [26].",
            "startOffset": 31395,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 53228,
            "parents": [],
            "secId": "s0080",
            "sentence": "All are available in a range of sizes suitable not only for processes of this scale, but for scaled-down process development and scaled-up production.",
            "startOffset": 53078,
            "title": "Discussion"
        },
        {
            "endOffset": 26623,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "For the avoidance of doubt, throughout this manuscript \u2018Merck\u2019 refers to the European entity \u2018Merck KGaA\u2019, known as \u2018MilliporeSigma\u2019 in North America.",
            "startOffset": 26473,
            "title": "Note regarding materials"
        },
        {
            "endOffset": 21434,
            "parents": [],
            "secId": "s0005",
            "sentence": "This approach is incapable of delivering a rapid response to emerging pathogens.",
            "startOffset": 21354,
            "title": "Introduction"
        },
        {
            "endOffset": 30281,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Except for the initial small-scale comparison of filters, for which a variety of 23 cm2 units were used (Fig. 2), 140 cm2 Millistak+\u00ae HC Pro depth filters with C0SP media filters were used (Merck).",
            "startOffset": 30084,
            "title": "Lysis, nucleic acid digestion and clarification"
        },
        {
            "endOffset": 23714,
            "parents": [],
            "secId": "s0005",
            "sentence": "In keeping with this potential \u2013 and also the fact that adenovirus-based gene therapy has been intensively investigated \u2013 there is extensive literature regarding GMP-compliant adenovirus production processes.",
            "startOffset": 23506,
            "title": "Introduction"
        },
        {
            "endOffset": 45763,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Further diafiltration beyond 6 DV achieved no further reduction in residuals.",
            "startOffset": 45686,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 27428,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 27145,
                    "startOffset": 27141
                },
                "b0125": {
                    "endOffset": 27367,
                    "startOffset": 27363
                }
            },
            "secId": "s0020",
            "sentence": "The ChAdOx1 RVF vaccine used here was similar to that previously reported [24], with the exception of modified codon usage in the GnGc transgene sequence, designed to avoid repetitive sequence: it is a vector based upon the Y25 chimpanzee adenovirus serotype, with modifications to the E4 region [25], expressing Rift Valley Fever virus glycoproteins Gn and Gc.",
            "startOffset": 27067,
            "title": "Viruses"
        },
        {
            "endOffset": 22386,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 22385,
                    "startOffset": 22380
                },
                "b0010": {
                    "endOffset": 22385,
                    "startOffset": 22380
                }
            },
            "secId": "s0005",
            "sentence": "Among the major classes of viral vectors, adenoviruses are arguably the most versatile and potent in inducing a combined antibody and T cell response [1,2].",
            "startOffset": 22230,
            "title": "Introduction"
        },
        {
            "endOffset": 34138,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Subsequently, elution characteristics of ChAd63 ME-TRAP and ChAdOx1 RVF were investigated in similar linear gradient elution experiments using Mustang Q Acrodisc capsules.",
            "startOffset": 33967,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 25777,
            "parents": [],
            "secId": "s0005",
            "sentence": "This process is robust but is labour-intensive, not scalable, requires a preceding period of product-specific process development, and limits cleanroom throughput to around three batches per year.",
            "startOffset": 25581,
            "title": "Introduction"
        },
        {
            "endOffset": 35708,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Diafiltered lysate was loaded at a flow rate of 40\u201345 mL/min and followed by a wash with 10\u201315 column volumes of loading buffer.",
            "startOffset": 35580,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 39042,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 39041,
                    "startOffset": 39037
                }
            },
            "secId": "s0055",
            "sentence": "A major cause of the need for product-specific optimisation of adenovirus vector production processes is the fact that some transgenes have a marked impact upon the growth of adenovirus vectors [20].",
            "startOffset": 38843,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 51129,
            "parents": [],
            "secId": "s0080",
            "sentence": "These vessels could readily be used in any cleanroom with existing capability to grow mammalian cells in suspension in shake flasks: at this scale, the only gas required in addition to CO2 is a 640L (under-bench) medical air cylinder.",
            "startOffset": 50895,
            "title": "Discussion"
        },
        {
            "endOffset": 41728,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "At 42\u201346 h, the majority of virus remains cell associated; by 96 h, much of the virus is in supernatant.",
            "startOffset": 41624,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 24538,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 24537,
                    "startOffset": 24533
                }
            },
            "secId": "s0005",
            "sentence": "Most previous publications describing adenovirus production processes have reported careful optimization of the manufacture of a single vector, often using the AdHu5 serotype and/or model transgenes such as green fluorescent protein (both lacking relevance to most clinical vaccine development) [11].",
            "startOffset": 24238,
            "title": "Introduction"
        },
        {
            "endOffset": 33347,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "In the case of the NatriFlo\u00ae HD-Q device, virus in the above bis-tris-based loading buffer was diluted 5-fold into a phosphate-based loading buffer prepared by titrating 50 mM orthophosphoric acid to pH 6.5 with sodium hydroxide.",
            "startOffset": 33118,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 36090,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "For ChAd63, due to the lower conductivity at which this vaccine eluted, only the loading buffer was used for washing, and elution buffer conductivity was adjusted to 26 mS/cm.",
            "startOffset": 35915,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 44001,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Having selected upstream process parameters in the above small-scale shake flask experiments, we proceeded to transfer the process to single-use stirred tank bioreactors.",
            "startOffset": 43831,
            "title": "A standardized upstream process using culture volumes of 2-4L achieves yields adequate for early-phase clinical trials"
        },
        {
            "endOffset": 26438,
            "parents": [],
            "secId": "s0005",
            "sentence": "Throughout, we have sought to make the process as simple as possible, using entirely off-the-shelf materials and disposable product-contact parts, with the aim of facilitating adoption by facilities with little or no experience of adenovirus production.",
            "startOffset": 26185,
            "title": "Introduction"
        },
        {
            "endOffset": 22230,
            "parents": [],
            "secId": "s0005",
            "sentence": "In principle, manufacture of such vectors should be similar regardless of the encoded antigen.",
            "startOffset": 22136,
            "title": "Introduction"
        },
        {
            "endOffset": 32103,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "This step was performed using either PES flat sheet modules (Pellicon\u00ae 2 Mini as above, or in one case a smaller Pellicon\u00ae XL50 module) or using 300 kDa MWCO PES MidiKros hollow fibre units (Spectrum Laboratories).",
            "startOffset": 31889,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 40286,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 40210,
                    "startOffset": 40206
                },
                "b0115": {
                    "endOffset": 40285,
                    "startOffset": 40281
                },
                "b0120": {
                    "endOffset": 40154,
                    "startOffset": 40150
                }
            },
            "secId": "s0055",
            "sentence": "We selected vectors encoding a variety of transgenes: \u2018ChAdOx1 RVF\u2019 encoding the GnGc antigen of Rift Valley fever virus (RVF) [24]; \u2018ChAdOx2 RabG\u2019 encoding rabies virus glycoprotein [22], and \u2018ChAd63 ME-TRAP\u2019 encoding a previously described malaria antigen [23].",
            "startOffset": 40023,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 38626,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0150": {
                    "endOffset": 38625,
                    "startOffset": 38618
                },
                "b0155": {
                    "endOffset": 38625,
                    "startOffset": 38618
                }
            },
            "secId": "s0045",
            "sentence": "Residual host cell DNA was quantified using a previously reported quantitative PCR method targeting a 94 base pair amplicon within the Alu repeats (which comprise 11% of the human genome and have a copy number >1 million/genome) [30,31].",
            "startOffset": 38389,
            "title": "Assessment of product quality"
        },
        {
            "endOffset": 27884,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "A master cell bank of HEK293 T-rex cells (Invitrogen) was produced under GMP conditions and subjected to testing compliant with pharmacopoeial requirements.",
            "startOffset": 27728,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 39474,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Unfortunately however, such cell lines have not been widely accessible for GMP manufacture in suspension culture.",
            "startOffset": 39361,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 32369,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "A retentate pinch valve was used to target a permeate flow rate of 0.83 L/min/m2, which was matched by the rate of addition of fresh A438 buffer to the system by a transfer pump.",
            "startOffset": 32191,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 32958,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Small-scale anion exchange to guide media selection was performed using an Akta Purifier (GE) and scale-down columns/capsules: 0.18 mL bed volume Mustang Q Acrodiscs (Pall); 1 mL CIMmultus QA-1 monoliths (BIA Separations); and 0.2 mL bed volume NatriFlo\u00ae HD-Q Recon Mini discs (Merck).",
            "startOffset": 32673,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 37786,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0145": {
                    "endOffset": 37785,
                    "startOffset": 37781
                }
            },
            "secId": "s0045",
            "sentence": "The relative protein content of the upper (empty capsid) and lower (genome-containing virus particle) bands were then quantified by running SDS-PAGE gels (as above) followed by staining using Silver Express (ThermoFisher) and densitometry, as previously reported [29].",
            "startOffset": 37518,
            "title": "Assessment of product quality"
        },
        {
            "endOffset": 52154,
            "parents": [],
            "secId": "s0080",
            "sentence": "Pharmaceutical-grade Benzonase\u00ae at this concentration costs c. USD 150 per liter, or c. USD 0.15 per vaccine dose.",
            "startOffset": 52040,
            "title": "Discussion"
        },
        {
            "endOffset": 44455,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Subsequent work with ChAdOx1 RVF and ChAd63 ME-TRAP was performed using Mobius\u00ae vessels.",
            "startOffset": 44367,
            "title": "A standardized upstream process using culture volumes of 2-4L achieves yields adequate for early-phase clinical trials"
        },
        {
            "endOffset": 25580,
            "parents": [],
            "secId": "s0005",
            "sentence": "This has been accomplished using a simple method involving a shake-flask-based upstream process and ultracentrifugation-based downstream process.",
            "startOffset": 25435,
            "title": "Introduction"
        },
        {
            "endOffset": 55906,
            "parents": [],
            "secId": "s0080",
            "sentence": "Our downstream process is thus strikingly straightforward and accessible to any GMP facility with minimal equipment investment: the only requirements are peristaltic pumps and the Pendotech sensor monitoring apparatus (total one-off cost < USD 30,000).",
            "startOffset": 55654,
            "title": "Discussion"
        },
        {
            "endOffset": 40576,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Cell density was 1.5 \u00d7 106 cells/mL at the time of infection, reduced to 0.6 \u00d7 106 cells/mL by addition of a 1.5 volume feed 3 h after infection.",
            "startOffset": 40431,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 57919,
            "parents": [],
            "secId": "s0080",
            "sentence": "The key rate-limiting step in the production of GMP adenovirus in the outbreak-response context is now the rescue of virus and production of a suitable inoculum (c. 2 \u00d7 1010 IU) to initiate a process such as ours.",
            "startOffset": 57706,
            "title": "Discussion"
        },
        {
            "endOffset": 43353,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "At 23 cm2 scale, the fully synthetic Millistak+\u00ae HC Pro C0SP filter (MilliporeSigma) was found to achieve 90% turbidity reduction (70 to 7 nephelometric turbidity units [NTU]) with no evidence of turbidity breakthrough at 200 L/m2 and back-pressure < 3 psi (Fig. 2B).",
            "startOffset": 43086,
            "title": "Small-scale development of a simple lysis and clarification process"
        },
        {
            "endOffset": 53580,
            "parents": [],
            "secId": "s0080",
            "sentence": "Our primary measurements of binding capacity were made using pre-purified virus, which will have favoured high capacity (as compared to using a load including impurities).",
            "startOffset": 53409,
            "title": "Discussion"
        },
        {
            "endOffset": 24238,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 24237,
                    "startOffset": 24230
                },
                "b0095": {
                    "endOffset": 24237,
                    "startOffset": 24230
                }
            },
            "secId": "s0005",
            "sentence": "More recently, membrane-based and monolith-based chromatography have been used [18,19].",
            "startOffset": 24151,
            "title": "Introduction"
        },
        {
            "endOffset": 43710,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Additional flushing with 1 M NaCl recovered minimal extra virus (<2% of load).",
            "startOffset": 43632,
            "title": "Small-scale development of a simple lysis and clarification process"
        },
        {
            "endOffset": 33966,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "After wash of >10 media bed volumes with loading buffer, a linear gradient of increasing proportion of buffer B in loading buffer was applied.",
            "startOffset": 33824,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 34842,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Buffer conductivity was selected on the basis of the conductivity value at the centre of the virus elution peak in the above linear gradient experiments, such that wash buffer conductivity was 3\u20134 mS/cm lower than this value, and elution buffer conductivity 2\u20134 mS/cm higher.",
            "startOffset": 34567,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 44760,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Maximal throughput was 285 L/m2 (4L), with no turbidity breakthrough observed.",
            "startOffset": 44682,
            "title": "A standardized upstream process using culture volumes of 2-4L achieves yields adequate for early-phase clinical trials"
        },
        {
            "endOffset": 35516,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Single-use UV absorbance, conductivity and pressure sensors (Pendotech) were used unless otherwise stated in results/figure legend.",
            "startOffset": 35385,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 29299,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Three hours later, 1.5 volumes of fresh complete medium was added.",
            "startOffset": 29233,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 36989,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "ce.section_vbt_rfj_4hb",
            "sentence": "All samples were pre-treated with Benzonase\u00ae, to remove unencapsidated viral DNA, followed by proteinase K treatment to release encapsidated genomes.",
            "startOffset": 36840,
            "title": "Product yield quantification"
        },
        {
            "endOffset": 39749,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We and most other adenovirus manufacturing facilities have thus continued to use non-tet-repressing cells for GMP manufacture, requiring empirical determination of optimal time of harvest (ToH) and multiplicity of infection (MOI) for individual viruses prior to manufacture.",
            "startOffset": 39475,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 53077,
            "parents": [],
            "secId": "s0080",
            "sentence": "A variety of commercial anion exchange products were shown to provide acceptable results; notably, our results are, to our knowledge, the first published report of the use of the NatriFlo\u00ae HD-Q hydrogel membrane device for viral purification.",
            "startOffset": 52835,
            "title": "Discussion"
        },
        {
            "endOffset": 44366,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "We obtained satisfactory results with both 2L cultures in the Mobius\u00ae 3L (MilliporeSigma; maximum working volume 2.4L; we occasionally used two such vessels in parallel for a 4L total culture volume), and 3.2L cultures in the BioBlu 3c (Eppendorf; maximum working volume 3.8L).",
            "startOffset": 44089,
            "title": "A standardized upstream process using culture volumes of 2-4L achieves yields adequate for early-phase clinical trials"
        },
        {
            "endOffset": 54799,
            "parents": [],
            "secId": "s0080",
            "sentence": "It may be that chromatographic differences between viruses sharing similar hexon charges are attributable to differing charges on other structural proteins.",
            "startOffset": 54643,
            "title": "Discussion"
        },
        {
            "endOffset": 30013,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "DO and pH control of the bioreactors was de-activated, but agitation and heating to 37 \u00b0C continued.",
            "startOffset": 29913,
            "title": "Lysis, nucleic acid digestion and clarification"
        },
        {
            "endOffset": 24702,
            "parents": [],
            "secId": "s0005",
            "sentence": "Marked differences between the growth characteristics of different viruses are observed when varying adenovirus serotypes and pathogen-derived transgenes are used.",
            "startOffset": 24539,
            "title": "Introduction"
        },
        {
            "endOffset": 50323,
            "parents": [],
            "secId": "s0080",
            "sentence": "The resulting process should be suitable for adoption by any facility with competence in routine bioprocess procedures (mammalian cell culture, bioreactor batch processes, tangential flow filtration and chromatography).",
            "startOffset": 50104,
            "title": "Discussion"
        },
        {
            "endOffset": 48151,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The only difference between the processes for the different viruses was the choice of anion exchange wash and elution conductivity (shown in Fig. 5B), based upon the differing elution characteristics observed in small-scale experiments (Fig. 4K and L).",
            "startOffset": 47899,
            "title": "2-4L downstream process yields product suitable for early-phase clinical trials"
        },
        {
            "endOffset": 46271,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "As compared to bead-based resins such matrices provide much improved convective access for large species such as viruses to the binding groups, higher binding capacities for such species, and substantially higher flow rate: matrix volume ratios.",
            "startOffset": 46026,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 50103,
            "parents": [],
            "secId": "s0080",
            "sentence": "We have aimed for simplicity and transferability in view of increasing interest in the production of adenovirus vectors in diverse contexts including \u2013 though not limited to \u2013 use in low and middle-income countries, in the response to outbreaks of emerging pathogens, and veterinary use.",
            "startOffset": 49816,
            "title": "Discussion"
        },
        {
            "endOffset": 42659,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "We next sought to implement a straightforward procedure for cell lysis, host cell DNA reduction and clarification.",
            "startOffset": 42545,
            "title": "Small-scale development of a simple lysis and clarification process"
        },
        {
            "endOffset": 47189,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "It is likely that a scaled-up process could have been designed using any of these media, but for further work, we selected Mustang Q capsules on the basis of binding capacity, product recovery and host cell protein reduction.",
            "startOffset": 46964,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 46566,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "For the purposes of manufacture of small GMP batches, they also have the substantial advantage of the off-the-shelf availability of GMP-suitable disposable capsules in sizes suitable for purification of \u223c1 \u00d7 1014 VP, avoiding the need for packing of custom-sized columns with bead-based resins.",
            "startOffset": 46272,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 32190,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Whichever module was used, feed flow rates for this second TFF step were 2.4 L/min/m2.",
            "startOffset": 32104,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 23024,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 23023,
                    "startOffset": 23018
                },
                "b0040": {
                    "endOffset": 23023,
                    "startOffset": 23018
                }
            },
            "secId": "s0005",
            "sentence": "Rare human serotypes may have similar properties [7,8].",
            "startOffset": 22969,
            "title": "Introduction"
        },
        {
            "endOffset": 22968,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 22967,
                    "startOffset": 22962
                },
                "b0030": {
                    "endOffset": 22967,
                    "startOffset": 22962
                }
            },
            "secId": "s0005",
            "sentence": "These have been shown to be safe and to have excellent immunogenicity in various human populations, including African children and adults, without any patient selection on the basis of pre-existing anti-vector immunity [5,6].",
            "startOffset": 22743,
            "title": "Introduction"
        },
        {
            "endOffset": 53408,
            "parents": [],
            "secId": "s0080",
            "sentence": "We observed substantially higher dynamic binding capacities than some previous reports for similar media- substantially in excess of 1 \u00d7 1013 VP per mL of bed for all three media.",
            "startOffset": 53229,
            "title": "Discussion"
        },
        {
            "endOffset": 52835,
            "parents": [],
            "secId": "s0080",
            "sentence": "The conditions we used reduced host cell DNA to beneath regulatorily-accepted levels of 10 ng per human dose prior to clarification; a considerably higher level at this stage would be expected to be reduced within acceptable limits by the downstream process.",
            "startOffset": 52577,
            "title": "Discussion"
        },
        {
            "endOffset": 54949,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 54948,
                    "startOffset": 54944
                }
            },
            "secId": "s0080",
            "sentence": "The serotypes we tested are representative of the diversity of major structural protein (hexon and fiber) sequences within adenovirus species E [25].",
            "startOffset": 54800,
            "title": "Discussion"
        },
        {
            "endOffset": 53975,
            "parents": [],
            "secId": "s0080",
            "sentence": "Such capacities have clear beneficial implications for process scalability and cost-effectiveness; Mustang Q units are available with bed volumes up to 780 mL, which our data suggests would be adequate for purification of nearly a million human doses.",
            "startOffset": 53724,
            "title": "Discussion"
        },
        {
            "endOffset": 27704,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The purified virus inocula used to infect cultures, for small-scale gradient-elution ion exchange experiments and as standards in quality control assays were produced by caesium chloride density-gradient ultracentrifugation by the Jenner Institute Viral Vector Core Facility.",
            "startOffset": 27429,
            "title": "Viruses"
        },
        {
            "endOffset": 58419,
            "parents": [],
            "secId": "s0085",
            "sentence": "The study was performed in collaboration between the University of Oxford and Merck KGaA; both partners reviewed the manuscript prior to submission.",
            "startOffset": 58271,
            "title": "Funding"
        },
        {
            "endOffset": 34566,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Wash and elution buffers were prepared by mixing loading buffer with buffer B until the desired conductivity was obtained.",
            "startOffset": 34444,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 57372,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 57371,
                    "startOffset": 57367
                }
            },
            "secId": "s0080",
            "sentence": "Among vaccines of a single adenovirus serotype, however, transgene repression should minimize differences in growth kinetics, and chromatographic characteristics are believed to be determined by the (constant) structural proteins rather than the (varying) transgene [36].",
            "startOffset": 57101,
            "title": "Discussion"
        },
        {
            "endOffset": 32440,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "This was typically achieved with transmembrane pressure of c. 0.5 bar.",
            "startOffset": 32370,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 46730,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "We observed satisfactory results with three such matrices: Mustang Q membrane capsules; NatriFlo\u00ae HD-Q hydrogel membrane capsules; and CIM-QA monoliths (Fig. 4A\u2013J).",
            "startOffset": 46566,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 48622,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Recovery at each process step is shown in Table 2; substantial losses were noted during IEX for ChAdOx1, and at TFF2 in the single run using the Pellicon XL50 unit.",
            "startOffset": 48458,
            "title": "2-4L downstream process yields product suitable for early-phase clinical trials"
        },
        {
            "endOffset": 28247,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Cells were adapted to suspension growth in CD293 media with 4 mM L-glutamine (both from ThermoFisher), 10 \u00b5g/mL blasticidin (Melford Laboratories) and gradually reducing concentrations of foetal bovine serum (5% to 0.5%), in non-baffled polycarbonate Erlenmeyer flasks (Corning) in an ISF1-X shaking incubator (Kuhner) at 37 \u00b0C, 8% CO2, 100 RPM with 50 mm orbit.",
            "startOffset": 27885,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 37517,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "For quantification of empty viral capsids, purified virus was subjected to isopycnic ultracentrifugation in 1.35 g/mL CsCl for 18 h at 160,000 g.",
            "startOffset": 37372,
            "title": "Assessment of product quality"
        },
        {
            "endOffset": 52576,
            "parents": [],
            "secId": "s0080",
            "sentence": "Nonetheless our data (Fig. 2A) suggest that, if scaling up this process, the concentration of Benzonase\u00ae used, or the digestion time, could be considerably reduced while maintaining acceptable host cell DNA levels and without requiring any other change to the method.",
            "startOffset": 52309,
            "title": "Discussion"
        },
        {
            "endOffset": 21744,
            "parents": [],
            "secId": "s0005",
            "sentence": "It is also unsuited to the development of \u2018niche\u2019 vaccines for diseases with small commercial markets- for example human diseases which are significant problems only within a restricted geographical area, livestock diseases predominantly affecting low-income countries, or even \u2018personalized\u2019 cancer vaccines.",
            "startOffset": 21435,
            "title": "Introduction"
        },
        {
            "endOffset": 54642,
            "parents": [],
            "secId": "s0080",
            "sentence": "The report correlating elution characteristics with charge found this relationship when comparing viruses with hexon charge spanning the range \u221214 to \u221228, while the relationship was imperfect when comparing viruses with smaller differences.",
            "startOffset": 54402,
            "title": "Discussion"
        },
        {
            "endOffset": 36422,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 36421,
                    "startOffset": 36417
                }
            },
            "secId": "ce.section_vbt_rfj_4hb",
            "sentence": "Infectious units were quantified by a cell-based infectivity assay which has also been described previously [25].",
            "startOffset": 36309,
            "title": "Product yield quantification"
        },
        {
            "endOffset": 32641,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "After the second TFF, the product was sterilized by passage through successive 0.45 \u00b5m and 0.2 \u00b5m filters (Millipak-20, 100 cm2 membrane area, Merck).",
            "startOffset": 32491,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 38389,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Residual benzonase was quantified using the Benzonase ELISA kit II (Merck), according to the manufacturer\u2019s instructions.",
            "startOffset": 38268,
            "title": "Assessment of product quality"
        },
        {
            "endOffset": 23506,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 23289,
                    "startOffset": 23286
                },
                "b0050": {
                    "endOffset": 23505,
                    "startOffset": 23501
                }
            },
            "secId": "s0005",
            "sentence": "An adenovirus-vectored vaccine against Ebola has been licensed in China [9] and numerous candidates are in clinical trials and advanced pre-clinical development, targeting diseases including malaria, Middle East respiratory syndrome, respiratory syncytial virus and a variety of cancers [10].",
            "startOffset": 23214,
            "title": "Introduction"
        },
        {
            "endOffset": 41361,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "For all viruses, yields exceeding 4 \u00d7 1010 virus particles and 5 \u00d7 108 infectious units per mL of culture were achieved between 42 and 46 h post-infection at either cell density (Fig. 1).",
            "startOffset": 41174,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 50894,
            "parents": [],
            "secId": "s0080",
            "sentence": "Of the two bioreactor vessels we used for the upstream process, the BioBlu vessel (Eppendorf) has the advantage of non-invasive pH and DO sensing; nonetheless, given the relatively low cost of invasive pH and DO sensors compatible with the Mobius\u00ae vessel (c. USD 2000), these could be regarded as single-use items for a GMP production run.",
            "startOffset": 50555,
            "title": "Discussion"
        },
        {
            "endOffset": 45685,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "This achieved reduction of >95% in residual host-cell protein and reduced host-cell DNA to undetectable levels.",
            "startOffset": 45574,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 21939,
            "parents": [],
            "secId": "s0005",
            "sentence": "In contrast \u2018platform technologies\u2019 for subunit vaccines allow the application of a single vaccine production method to the induction of immune responses against any protein antigen of interest.",
            "startOffset": 21745,
            "title": "Introduction"
        },
        {
            "endOffset": 49488,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "P:I ratios of these simian adenovirus serotypes are commonly higher than those usually obtained with AdHu5, even when purification is by ultracentrifugation: values in the range 50\u2013120 are commonly obtained after lab-scale ultracentrifugation (based upon experience of >1000 virus preparations by the Jenner Institute Viral Vector Core Facility), and batches prepared for clinical trials at our Clinical Biomanufacturing Facility have had P:I ratios in the range 50\u2013200.",
            "startOffset": 49018,
            "title": "2-4L downstream process yields product suitable for early-phase clinical trials"
        },
        {
            "endOffset": 56869,
            "parents": [],
            "secId": "s0080",
            "sentence": "This method can be implemented for a new vaccine with minimal or even no vaccine-specific process development.",
            "startOffset": 56759,
            "title": "Discussion"
        },
        {
            "endOffset": 38268,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "In some cases an in-house version of the same assay was used, employing the same standards and goat anti-HEK293 HCP antibody (both from Cygnus Technologies), with the antibody used in unconjugated and horseradish-peroxidase-conjugated formats (produced using Lynx Rapid kit [Bio-Rad]) as capture and detection antibodies respectively.",
            "startOffset": 37934,
            "title": "Assessment of product quality"
        },
        {
            "endOffset": 58160,
            "parents": [],
            "secId": "s0085",
            "sentence": "This work was supported by Merck KGaA, the UK Medical Research Council (grant MR/P017339/1), and the UK Engineering and Physical Sciences Research Council (grant EP/R013756/1).",
            "startOffset": 57984,
            "title": "Funding"
        },
        {
            "endOffset": 56663,
            "parents": [],
            "secId": "s0080",
            "sentence": "Overall DSP recovery was in some cases as low as 20%, offering clear scope for further improvement in the overall process yield; analysis of step recovery from individual runs indicated particular potential for improvement of the ChAdOx1 RVF IEX step and the consistency of performance of the TFF2 step.",
            "startOffset": 56360,
            "title": "Discussion"
        },
        {
            "endOffset": 32490,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Permeate control was not used for the second TFF.",
            "startOffset": 32441,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 33611,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Dynamic binding capacity (DBC) was assessed by loading excess of a pre-purified ChAdOx2 RabG sample in loading buffer, at the lower end of manufacturers\u2019 recommended flow rate ranges for each ion exchange medium, until breakthrough was observed (assessed by A280).",
            "startOffset": 33347,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 35914,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "For ChAdOx1, wash conductivity was identical to that of ChAdOx2 and elution conductivity was higher (37 mS/cm).",
            "startOffset": 35803,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 28727,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Mobius\u00ae 3L (Merck) and BioBlu 3c (Eppendorf) single-use bioreactor vessels were used in accordance with the manufacturers\u2019 instructions.",
            "startOffset": 28591,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 46025,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "We focused our efforts upon membrane and monolith matrices with quaternary amine chemistry.",
            "startOffset": 45934,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 35222,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Eluted virus was collected during application of elution buffer, then analysed by quantitative PCR (qPCR) for VP quantification and by ELISA for residual host cell protein (see below).",
            "startOffset": 35038,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 45573,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "With Pellicon\u00ae 2 Mini devices, recovery was typically c. 80% for all viruses after 10-fold concentration and 6 diavolumes (DV) of buffer exchange into anion exchange loading buffer.",
            "startOffset": 45392,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 29232,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Vessels were seeded with 800 mL (Mobius\u00ae) or 1.2 L (BioBlu) of culture at 1.5\u20132.0 \u00d7 106 cells/mL, then inoculated with virus at an MOI of 3.",
            "startOffset": 29092,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 31724,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "After 6 to 10-fold concentration, clarified lysate was diafiltered into ion exchange loading buffer comprising 100 mM NaCl, 1 mM MgCl2, 0.1% v/v polysorbate 20, 5% w/v sucrose, 50 mM bis-tris, pH 6.5.",
            "startOffset": 31524,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 44681,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Clarification using 140 cm2 Millistak+\u00ae HC Pro depth filters with C0SP media filters resulted in post-clarification turbidity of \u22646 NTU for all runs with all viruses.",
            "startOffset": 44515,
            "title": "A standardized upstream process using culture volumes of 2-4L achieves yields adequate for early-phase clinical trials"
        },
        {
            "endOffset": 47899,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Drawing upon the experience from the above scaled-down experiments, we implemented a downstream process as shown in Fig. 5A. To ensure that all product-contact components were disposable, single-use liners (Merck) were used with the Pellicon\u00ae 2 Mini TFF cassettes, and chromatography monitoring employed single-use pressure, conductivity and UV spectrometry sensor flow cells (Pendotech) (data shown in Fig. 5B).",
            "startOffset": 47487,
            "title": "2-4L downstream process yields product suitable for early-phase clinical trials"
        },
        {
            "endOffset": 55980,
            "parents": [],
            "secId": "s0080",
            "sentence": "Our final process provided USP yields consistently > 2500 doses per litre.",
            "startOffset": 55906,
            "title": "Discussion"
        },
        {
            "endOffset": 56359,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 56249,
                    "startOffset": 56245
                },
                "b0060": {
                    "endOffset": 56358,
                    "startOffset": 56354
                }
            },
            "secId": "s0080",
            "sentence": "Yield per infected cell ranged from 5.5 \u00d7 104\u20131.4 \u00d7 105 VP, favourably comparable to values previously reported in a review encompassing a variety of cell types, media, and process types (HEK293 and PER.C6; adherent and suspension; batch, fed batch and perfusion) [11], and also comparable also to those achieved in more recent perfusion-based processes using PER.C6 cells [12].",
            "startOffset": 55981,
            "title": "Discussion"
        },
        {
            "endOffset": 27066,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Briefly, ChAdOx2 RabG is a vector expressing the rabies virus glycoprotein, based upon the AdC68 chimpanzee adenovirus serotype but with modifications to the E4 region; ChAd63 ME-TRAP is a chimpanzee adenovirus serotype 63 vector expressing a multi-epitope string and thrombospondin related adhesive protein from Plasmodium falciparum.",
            "startOffset": 26731,
            "title": "Viruses"
        },
        {
            "endOffset": 45933,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "We next sought to compare a range of commercially available anion exchange media for use in bind - wash \u2013 elute mode in small-scale experiments using up to 1 mL of media.",
            "startOffset": 45763,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 53723,
            "parents": [],
            "secId": "s0080",
            "sentence": "Nonetheless, we routinely observed total process yields of 1 \u00d7 1014 \u2013 2 \u00d7 1014 VP using the 10 mL Mustang Q capsule in our full-scale process.",
            "startOffset": 53581,
            "title": "Discussion"
        },
        {
            "endOffset": 37372,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "SDS-PAGE was performed using 4\u201312% Bis-Tris gels, MOPS running buffer and NuPAGE sample buffer supplemented with DTT (all from ThermoFisher), stained with Quick Coomassie (Generon) and imaged using a ChemiDoc system (Bio-Rad).",
            "startOffset": 37146,
            "title": "Assessment of product quality"
        },
        {
            "endOffset": 48381,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "For ChAd63 ME-TRAP washing was performed with loading buffer but a higher-conductivity wash was omitted in view of the lower elution conductivity and the modest amount of impurity eluted by the wash step with the other serotypes.",
            "startOffset": 48152,
            "title": "2-4L downstream process yields product suitable for early-phase clinical trials"
        },
        {
            "endOffset": 24860,
            "parents": [],
            "secId": "s0005",
            "sentence": "This necessitates optimization of production processes for each individual virus, which is clearly undesirable for low-cost manufacture or outbreak response.",
            "startOffset": 24703,
            "title": "Introduction"
        },
        {
            "endOffset": 41888,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We therefore proceeded to use similar conditions in all subsequent work: ToH of 42\u201346 h; MOI of 3; cell density of 1.5\u20132.0 \u00d7 106 cells/mL at point of infection.",
            "startOffset": 41728,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 22135,
            "parents": [],
            "secId": "s0005",
            "sentence": "A key group of such \u2018platforms\u2019 are viral vector vaccines, which use a replication-deficient virus to deliver a transgene encoding the antigen of interest for expression in the recipient\u2019s cells.",
            "startOffset": 21940,
            "title": "Introduction"
        },
        {
            "endOffset": 29912,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Lysis was initiated 42 h after infection by addition of 1/9 culture volume of buffer containing 10% v/v polysorbate 20, 50% w/v sucrose, 20 mM MgCl2, 500 mM Tris pH 8.0, plus Benzonase\u00ae (all from Merck) to a final in-culture concentration of 60 units/mL.",
            "startOffset": 29658,
            "title": "Lysis, nucleic acid digestion and clarification"
        },
        {
            "endOffset": 41174,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Given our aim to develop a simple and transferable method, we restricted ourselves to lower cell densities and simply sought to establish a readily-achieved window of densities achieving acceptable yield.",
            "startOffset": 40970,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 58501,
            "parents": [],
            "secId": "s0085",
            "sentence": "The other funders had no input to the design of the study or decision to publish.",
            "startOffset": 58420,
            "title": "Funding"
        },
        {
            "endOffset": 49815,
            "parents": [],
            "secId": "s0080",
            "sentence": "Here, we focused upon developing a process which could be rapidly adapted to any adenovirus serotype/transgene combination to produce a small GMP batch suitable for early-phase clinical trials.",
            "startOffset": 49622,
            "title": "Discussion"
        },
        {
            "endOffset": 58591,
            "parents": [],
            "secId": "s0085",
            "sentence": "Correspondence and requests for materials can be addressed to sandy.douglas@ndm.ox.ac.uk.",
            "startOffset": 58502,
            "title": "Funding"
        },
        {
            "endOffset": 33823,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "DBC was defined as the load at which breakthrough A280 exceeded that observed early during loading (i.e. flowthrough A280) by 10% of the difference between the A280 of the loaded sample and the flowthrough A280.",
            "startOffset": 33612,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 44810,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Yields are shown on a volumetric basis in Table 1.",
            "startOffset": 44760,
            "title": "A standardized upstream process using culture volumes of 2-4L achieves yields adequate for early-phase clinical trials"
        },
        {
            "endOffset": 56759,
            "parents": [],
            "secId": "s0080",
            "sentence": "Nonetheless, final yields were consistently more than adequate for early-phase clinical trials.",
            "startOffset": 56664,
            "title": "Discussion"
        },
        {
            "endOffset": 30677,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Prior to use, filters were equilibrated with 1% v/v polysorbate 20, 5% w/v sucrose, 2 mM MgCl2, 50 mM Tris pH 8.0; after completion of filtration of lysate, 140 cm2 filters were flushed with 750 mL of the same buffer.",
            "startOffset": 30460,
            "title": "Lysis, nucleic acid digestion and clarification"
        },
        {
            "endOffset": 51272,
            "parents": [],
            "secId": "s0080",
            "sentence": "Both manufacturers offer a family of larger vessels for scaled-up production (with somewhat more choice at the lower end in the BioBlu range).",
            "startOffset": 51130,
            "title": "Discussion"
        },
        {
            "endOffset": 29608,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "One-point calibration of the optical pH sensor was performed by taking a sample three hours after vessel set-up (allowing time for equilibration of the sensor, but before addition of the feed).",
            "startOffset": 29415,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 38701,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "The lower limit of our standard curve was 100 pg/mL for intact HEK293 DNA.",
            "startOffset": 38627,
            "title": "Assessment of product quality"
        },
        {
            "endOffset": 24999,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 24998,
                    "startOffset": 24991
                },
                "b0105": {
                    "endOffset": 24998,
                    "startOffset": 24991
                }
            },
            "secId": "s0005",
            "sentence": "In extreme cases, inhibition of viral growth by \u2018transgene toxicity\u2019 can result in failure of viral rescue or genetic instability [20,21].",
            "startOffset": 24861,
            "title": "Introduction"
        },
        {
            "endOffset": 54401,
            "parents": [],
            "secId": "s0080",
            "sentence": "At pH 7, predicted hexon net charges are \u221217.7 for ChAdOx2, \u221218.5 for ChAd63, and \u221219.7 for ChAdOx1.",
            "startOffset": 54301,
            "title": "Discussion"
        },
        {
            "endOffset": 37114,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "ce.section_vbt_rfj_4hb",
            "sentence": "Quantification was performed relative to a standard curve of purified, spectrophotometrically-quantified ChAdOx2 RabG virus.",
            "startOffset": 36990,
            "title": "Product yield quantification"
        },
        {
            "endOffset": 40969,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0055": {
                    "endOffset": 40968,
                    "startOffset": 40964
                }
            },
            "secId": "s0055",
            "sentence": "Previous work suggests cell-specific productivity is reduced at cell densities above those we tested unless more complex medium-exchange or perfusion methods are used [11].",
            "startOffset": 40797,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 48457,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "For each virus, we obtained >800 human doses from a 2\u20135 L culture (Table 1).",
            "startOffset": 48381,
            "title": "2-4L downstream process yields product suitable for early-phase clinical trials"
        },
        {
            "endOffset": 49017,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Product quality was within specifications accepted for clinical use by local regulators (particle:infectivity [P:I] ratio, A260:A280 ratio, residual host-cell protein, host-cell DNA, and benzonase), and results of further assays performed for information were also consistent with high quality product (empty capsid:VP ratio quantification and Coomassie-stained SDS-PAGE) (Table 1 and Fig. 5C).",
            "startOffset": 48623,
            "title": "2-4L downstream process yields product suitable for early-phase clinical trials"
        },
        {
            "endOffset": 25232,
            "parents": [],
            "secId": "s0005",
            "sentence": "Partly as a result of this variability, production of an initial Good Manufacturing Practice (GMP)-compliant batch of virus for early-phase clinical trials remains a bottleneck in the adenovirus-vectored vaccine development pipeline.",
            "startOffset": 24999,
            "title": "Introduction"
        },
        {
            "endOffset": 45047,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Upstream process yields per bioreactor vessel ranged from 7.2 \u00d7 1013 to 2.5 \u00d7 1014 VP [by qPCR] across four runs with ChAdOx2 RabG, two runs with ChAdOx1 RVF, and two runs with ChAd63 ME-TRAP, i.e. >2500 human doses of c. 2.5 \u00d7 1010 VP.",
            "startOffset": 44811,
            "title": "A standardized upstream process using culture volumes of 2-4L achieves yields adequate for early-phase clinical trials"
        },
        {
            "endOffset": 58270,
            "parents": [],
            "secId": "s0085",
            "sentence": "ADD is supported by the Wellcome Trust [grants 201477/Z/16/Z and 204826/Z/16/Z] and is a Jenner Investigator.",
            "startOffset": 58161,
            "title": "Funding"
        },
        {
            "endOffset": 39836,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We have now produced and tested a HEK293 T-rex cell bank which is suitable for GMP use.",
            "startOffset": 39749,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 35579,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Capsules were pre-equilibrated with loading buffer (as above).",
            "startOffset": 35517,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 29091,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "pH was regulated in the range 7.2\u20137.3 by addition of CO2 or 7.5% sodium bicarbonate solution (ThermoFisher) as required.",
            "startOffset": 28971,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 31252,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "For concentration and diafiltration of clarified lysate (the first TFF step, \u2018TFF1\u2032), feed flow rates of 6 L/min/m2 were used, with minimal transmembrane pressure (no pinch valve restriction).",
            "startOffset": 31060,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 21353,
            "parents": [],
            "secId": "s0005",
            "sentence": "Historically, development of novel vaccines has been a painstaking process taking many years and involving the development of entirely bespoke manufacturing processes.",
            "startOffset": 21186,
            "title": "Introduction"
        },
        {
            "endOffset": 43085,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "We compared a range of depth filters, seeking to identify a candidate which might be suitable for a single-step clarification process.",
            "startOffset": 42951,
            "title": "Small-scale development of a simple lysis and clarification process"
        },
        {
            "endOffset": 55069,
            "parents": [],
            "secId": "s0080",
            "sentence": "It would be of interest to extend the use of this process to clinically relevant serotypes of other adenovirus species.",
            "startOffset": 54950,
            "title": "Discussion"
        },
        {
            "endOffset": 43631,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "There was little difference between the filters in efficiency of product recovery (data not shown); subsequent experience with the Millistak+\u00ae HC Pro C0SP filter demonstrated recovery consistently > 90% (median 95%, range 91\u2013100, n = 4, based upon infectivity unit titrations).",
            "startOffset": 43354,
            "title": "Small-scale development of a simple lysis and clarification process"
        },
        {
            "endOffset": 30459,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "A flow rate of 3.3 L/min/m2 was used in early experiments (Fig. 2); this was subsequently accelerated to 6.6 L/min/m2 without detriment to turbidity reduction or virus recovery.",
            "startOffset": 30282,
            "title": "Lysis, nucleic acid digestion and clarification"
        },
        {
            "endOffset": 30083,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Two hours after addition of lysis buffer, clarification was initiated.",
            "startOffset": 30013,
            "title": "Lysis, nucleic acid digestion and clarification"
        },
        {
            "endOffset": 41528,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "\u2018Super-infecting\u2019 cells with an MOI of 10 achieved little additional yield versus an MOI of 3 (in fact reducing the amplification factor [output yield per input IU]).",
            "startOffset": 41362,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 40430,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "We examined virus yield over time in HEK293 T-rex cells in small-scale shake flasks (maximum culture volume 40 mL), comparing MOIs of 3 and 10.",
            "startOffset": 40287,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 40022,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0015": {
                    "endOffset": 40004,
                    "startOffset": 40001
                },
                "b0115": {
                    "endOffset": 40021,
                    "startOffset": 40017
                },
                "b0125": {
                    "endOffset": 39968,
                    "startOffset": 39964
                }
            },
            "secId": "s0055",
            "sentence": "We sought to investigate growth of vectors of three simian serotypes in these cells: ChAdOx1, a derivative of the Y25 serotype [25]; ChAdOx2, a derivative of AdC68 [3]; and ChAd63 [23].",
            "startOffset": 39837,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 26730,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 26729,
                    "startOffset": 26722
                },
                "b0115": {
                    "endOffset": 26729,
                    "startOffset": 26722
                }
            },
            "secId": "s0020",
            "sentence": "Derivation of the ChAdOx2 RabG and ChAd63 ME-TRAP vaccines has previously been described [22,23].",
            "startOffset": 26633,
            "title": "Viruses"
        },
        {
            "endOffset": 35037,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "After completion of loading, loading buffer, wash buffer, elution buffer and buffer B were applied in sequence, with 10 bed volumes or 10 mL (whichever was greater) of each buffer being applied.",
            "startOffset": 34843,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 23213,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 23212,
                    "startOffset": 23209
                }
            },
            "secId": "s0005",
            "sentence": "As a result, there has been significant investment by large pharmaceutical companies in the development of high-yielding and cost-effective large-scale adenovirus production processes [4].",
            "startOffset": 23025,
            "title": "Introduction"
        },
        {
            "endOffset": 35384,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "For at-scale chromatography, Mustang Q capsules with 10 mL bed volume (Pall) were used in peristaltic pump-driven rigs comprising Masterflex tubing (Cole Parmer).",
            "startOffset": 35222,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 36748,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "ce.section_vbt_rfj_4hb",
            "sentence": "Forward and reverse primers were GTGGGAAAAGTGACGTCAAACGAG and TGCATCCGCCTAGAAACACCTCA respectively.",
            "startOffset": 36649,
            "title": "Product yield quantification"
        },
        {
            "endOffset": 47326,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "To ascertain elution conditions for the ChAd63 and ChAdOx1 serotypes, we performed small-scale gradient elution from Mustang Q membranes.",
            "startOffset": 47189,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 54061,
            "parents": [],
            "secId": "s0080",
            "sentence": "We observed slightly different elution characteristics for the three tested serotypes.",
            "startOffset": 53975,
            "title": "Discussion"
        },
        {
            "endOffset": 40796,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Our aim was not to determine strictly optimal conditions (which would require a wider range of MOIs and cell densities), but instead to assess whether we could identify \u2018standard\u2019 conditions providing acceptable yields.",
            "startOffset": 40577,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 34443,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "To assess performance of the media under step elution conditions, diafiltered lysate containing ChAdOx2 RabG was loaded at manufacturers\u2019 recommended flow rates, up to a load of 5 \u00d7 1012 virus particles (VP) for the Mustang Q and NatriFlo\u00ae HD-Q capsules, and 1x1013 VP for the larger-volume CIM-QA column.",
            "startOffset": 34138,
            "title": "Anion exchange chromatography"
        },
        {
            "endOffset": 45391,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 45390,
                    "startOffset": 45380
                },
                "b0090": {
                    "endOffset": 45390,
                    "startOffset": 45380
                },
                "b0170": {
                    "endOffset": 45390,
                    "startOffset": 45380
                }
            },
            "secId": "s0070",
            "sentence": "Consistent with previous reports of TFF of adenovirus products using various devices with polyethersulfone (PES) membranes with 300 kDa molecular weight cut-off (MWCO), we obtained satisfactory results using 300 kDa MWCO BioMax\u00ae PES C-screen Pellicon\u00ae XL50 or Pellicon\u00ae 2 Mini devices (Merck) [14,18,34].",
            "startOffset": 45087,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 47405,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "ChAd63 ME-TRAP eluted at 24 mS/cm and ChAdOx1 RVF at 35 mS/cm (Fig. 4K and L).",
            "startOffset": 47327,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 31060,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Unless otherwise specified in the Results section, tangential flow filtration (TFF) was performed using Pellicon\u00ae 2 Mini cassettes with BioMax\u00ae polyethersulfone membranes and C-screens (Merck), in conjunction with Spectrum process reservoirs (Spectrum Laboratories), Masterflex tubing (ColeParmer) and single-use pressure sensors (Pendotech).",
            "startOffset": 30718,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 44088,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "For our initial work with ChAdOx2 RabG, we explored two single-use bioreactor systems.",
            "startOffset": 44002,
            "title": "A standardized upstream process using culture volumes of 2-4L achieves yields adequate for early-phase clinical trials"
        },
        {
            "endOffset": 22576,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 22575,
                    "startOffset": 22570
                },
                "b0020": {
                    "endOffset": 22575,
                    "startOffset": 22570
                }
            },
            "secId": "s0005",
            "sentence": "Viruses lacking E1 and E3 regions are replication-incompetent outside helper cells and a high level of assurance against the generation of replication-competent virus can be achieved [3,4].",
            "startOffset": 22387,
            "title": "Introduction"
        },
        {
            "endOffset": 28853,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "A GX bioreactor controller unit and C-BIO software (both from Global Process Control) were used to control both vessel types.",
            "startOffset": 28728,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 39360,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 39359,
                    "startOffset": 39346
                },
                "b0105": {
                    "endOffset": 39359,
                    "startOffset": 39346
                },
                "b0160": {
                    "endOffset": 39359,
                    "startOffset": 39346
                },
                "b0165": {
                    "endOffset": 39359,
                    "startOffset": 39346
                }
            },
            "secId": "s0055",
            "sentence": "We and others have previously reported that viruses carrying such \u2018toxic\u2019 transgenes can be rescued by incorporating \u2018tet operator\u2019 elements in the transgene promoter and growing the virus in cells such as HEK293 T-Rex (ThermoFisher) and Procell 92 which repress expression from such modified promoters [20,21,32,33].",
            "startOffset": 39043,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 55653,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 55651,
                    "startOffset": 55647
                }
            },
            "secId": "s0080",
            "sentence": "Given that residual host cell protein levels were within acceptable limits after single-step chromatography, we did not require or explore a \u2018polish\u2019 step (although we note the possibility of use of core\u2013shell octylamine resins (such as Captocore 700 [GE]) to provide such a polish in flow-through mode [16]).",
            "startOffset": 55344,
            "title": "Discussion"
        },
        {
            "endOffset": 29414,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "In the case of the BioBlu vessels, an OP-76 optical pH transducer (Eppendorf) was used for non-invasive pH sensing.",
            "startOffset": 29299,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 36648,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "ce.section_vbt_rfj_4hb",
            "sentence": "For in-process samples, genome-containing virus particles were quantified by TaqMan quantitative PCR (qPCR) using a probe set designed to bind a non-coding region of the adenoviral genome common to ChAdOx1, ChAdOx2 and ChAd63.",
            "startOffset": 36422,
            "title": "Product yield quantification"
        },
        {
            "endOffset": 46963,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Binding capacity, virus recovery, and host cell protein reduction are shown in Fig. 4J.",
            "startOffset": 46876,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 24150,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 24149,
                    "startOffset": 24142
                },
                "b0070": {
                    "endOffset": 24149,
                    "startOffset": 24142
                },
                "b0075": {
                    "endOffset": 24149,
                    "startOffset": 24142
                },
                "b0080": {
                    "endOffset": 24149,
                    "startOffset": 24142
                },
                "b0085": {
                    "endOffset": 24149,
                    "startOffset": 24142
                }
            },
            "secId": "s0005",
            "sentence": "Downstream processes have commonly made use of bead-based anion exchange resins, often with an additional polish step such as size exclusion, hydrophobic interaction or multi-modal core-shell (eg CaptoCore\u00ae) chromatography [13\u201317].",
            "startOffset": 23919,
            "title": "Introduction"
        },
        {
            "endOffset": 42475,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Nonetheless, up to 42\u201346 h, kinetics are sufficiently similar to allow use of this as a single ToH.",
            "startOffset": 42376,
            "title": "Vectors of three serotypes carrying three antigen transgenes have similar growth characteristics in tet-repressing suspension cells"
        },
        {
            "endOffset": 37933,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Residual host-cell protein (HCP) was quantified using the HEK293 HCP ELISA kit (Cygnus Technologies), according to the manufacturer\u2019s instructions.",
            "startOffset": 37786,
            "title": "Assessment of product quality"
        },
        {
            "endOffset": 52039,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 52038,
                    "startOffset": 52034
                }
            },
            "secId": "s0080",
            "sentence": "We were therefore satisfied with the host cell DNA reduction achieved with Benzonase\u00ae at 60 U/mL (and the ease of quantifying residual Benzonase\u00ae with an off-the-shelf ELISA kit), despite its relatively high cost as compared to alternative methods such as precipitation with domiphen [35].",
            "startOffset": 51750,
            "title": "Discussion"
        },
        {
            "endOffset": 49621,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 49620,
                    "startOffset": 49614
                },
                "b0055": {
                    "endOffset": 49620,
                    "startOffset": 49614
                }
            },
            "secId": "s0080",
            "sentence": "Methods for GMP production of a variety of adenovirus vectors at a variety of scales have previously been reported [4,11].",
            "startOffset": 49499,
            "title": "Discussion"
        },
        {
            "endOffset": 51604,
            "parents": [],
            "secId": "s0080",
            "sentence": "Due to our desire for simplicity and satisfactory results with this process, we deliberately did not pursue intensification of the upstream process (with more modern media formulations, fed batch or perfusion processes), but clearly there are a variety of options available to increase the volumetric yield of the upstream process.",
            "startOffset": 51273,
            "title": "Discussion"
        },
        {
            "endOffset": 51749,
            "parents": [],
            "secId": "s0080",
            "sentence": "Similarly, we prioritized simplicity over consumable costs (which are a relatively small component of the total cost of a GMP run of this scale).",
            "startOffset": 51604,
            "title": "Discussion"
        },
        {
            "endOffset": 55343,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 55342,
                    "startOffset": 55338
                },
                "b0185": {
                    "endOffset": 55261,
                    "startOffset": 55257
                }
            },
            "secId": "s0080",
            "sentence": "Encouraging such work, there are several reports of the application of TFF- and anion-exchange-based downstream processes to the species B adenovirus AdHu35 and the species C virus AdHu5 [37], and anion exchange has also been successfully applied to species D viruses [36].",
            "startOffset": 55070,
            "title": "Discussion"
        },
        {
            "endOffset": 25434,
            "parents": [],
            "secId": "s0005",
            "sentence": "Our own Clinical Biomanufacturing Facility (CBF) is among the most experienced facilities in manufacture of such batches, having produced GMP adenovirus for numerous clinical trials in the past decade.",
            "startOffset": 25233,
            "title": "Introduction"
        },
        {
            "endOffset": 36839,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "ce.section_vbt_rfj_4hb",
            "sentence": "A probe with sequence GAGAGCGCGGGAAAATTGAGTATT was labelled with TAMRA/FAM (ThermoFisher).",
            "startOffset": 36749,
            "title": "Product yield quantification"
        },
        {
            "endOffset": 44514,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Typical process parameter logging data is shown in Fig. 3.",
            "startOffset": 44456,
            "title": "A standardized upstream process using culture volumes of 2-4L achieves yields adequate for early-phase clinical trials"
        },
        {
            "endOffset": 28315,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Media with 0.5% serum is henceforth referred to as complete medium.",
            "startOffset": 28248,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 31394,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Diafiltration buffer feed rate was manually adjusted to match the permeate flow rate by maintaining a constant mass of the process reservoir.",
            "startOffset": 31253,
            "title": "Tangential flow and sterile filtration"
        },
        {
            "endOffset": 36308,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 36232,
                    "startOffset": 36228
                }
            },
            "secId": "ce.section_vbt_rfj_4hb",
            "sentence": "Purified genome-containing virus particles were quantified by UV spectrophotometry as previously described [28]; all results are based upon the mean of triplicate absorbance measurements.",
            "startOffset": 36121,
            "title": "Product yield quantification"
        },
        {
            "endOffset": 28970,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Dissolved oxygen (DO) was regulated at a setpoint of 50% air saturation by addition of medical air via microsparger.",
            "startOffset": 28854,
            "title": "Cells and bioreactors"
        },
        {
            "endOffset": 22742,
            "parents": [],
            "secId": "s0005",
            "sentence": "Pre-existing immunity to human adenoviruses in the human population may inhibit their effectiveness as vaccine vectors but can be overcome using simian adenoviruses.",
            "startOffset": 22577,
            "title": "Introduction"
        },
        {
            "endOffset": 54300,
            "parents": [],
            "refoffsets": {
                "b0180": {
                    "endOffset": 54264,
                    "startOffset": 54260
                }
            },
            "secId": "s0080",
            "sentence": "Although the salt concentration required to elute various adenovirus serotypes from anion exchange media has previously been reported to correlate with charge of the hexon, the major capsid protein [36], we did not observe such a pattern.",
            "startOffset": 54062,
            "title": "Discussion"
        },
        {
            "endOffset": 23918,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 23917,
                    "startOffset": 23911
                },
                "b0055": {
                    "endOffset": 23807,
                    "startOffset": 23803
                },
                "b0060": {
                    "endOffset": 23917,
                    "startOffset": 23911
                }
            },
            "secId": "s0005",
            "sentence": "Suspension HEK293 cells are commonly used in batch-mode stirred-tank upstream processes [11], although the highest volumetric yields have been reported in perfusion-based processes in PERC6 cells [4,12].",
            "startOffset": 23715,
            "title": "Introduction"
        },
        {
            "endOffset": 42951,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Starting from a culture infected with ChAdOx2 RabG (parameters as above), we observed rapid reduction in intact host cell DNA levels (as assessed by qPCR) during lysis with a detergent-based buffer in the presence of 60 units/mL Benzonase\u00ae during incubation with stirring at 37 \u00b0C (Fig. 2A).",
            "startOffset": 42660,
            "title": "Small-scale development of a simple lysis and clarification process"
        },
        {
            "endOffset": 57100,
            "parents": [],
            "secId": "s0080",
            "sentence": "Given one to two weeks, it is possible to perform a shake flask study to confirm optimal time of harvest, and a small-scale gradient-elution anion exchange experiment to confirm suitable chromatography elution +/- wash conditions.",
            "startOffset": 56870,
            "title": "Discussion"
        },
        {
            "endOffset": 46875,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Satisfactory separation with the NatriFlo\u00ae HD-Q capsule required transfer of the virus into phosphate buffer prior to application to the column.",
            "startOffset": 46731,
            "title": "Selection of downstream process media"
        },
        {
            "endOffset": 52308,
            "parents": [],
            "secId": "s0080",
            "sentence": "This is trivial in the context of manufacture of a Phase I clinical trial batch, and indeed might be tolerable for marketed products in certain contexts.",
            "startOffset": 52155,
            "title": "Discussion"
        },
        {
            "endOffset": 26184,
            "parents": [],
            "secId": "s0005",
            "sentence": "Although our principal focus has been the production of an initial GMP batch for early-phase clinical trials, we have aimed to use processing techniques suitable for subsequent scale-up.",
            "startOffset": 25998,
            "title": "Introduction"
        },
        {
            "endOffset": 50555,
            "parents": [],
            "secId": "s0080",
            "sentence": "Key elements are the use of a cell line which minimizes the need for virus/antigen specific growth optimization, and the use of entirely \u2018off-the-shelf\u2019 equipment and materials, with single-use product-contact materials throughout.",
            "startOffset": 50324,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X19305328",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Sofiya",
                "initial": "S.",
                "last": "Fedosyuk"
            },
            {
                "email": null,
                "first": "Thomas",
                "initial": "T.",
                "last": "Merritt"
            },
            {
                "email": null,
                "first": "Marco Polo",
                "initial": "M.P.",
                "last": "Peralta-Alvarez"
            },
            {
                "email": null,
                "first": "Susan J.",
                "initial": "S.J.",
                "last": "Morris"
            },
            {
                "email": null,
                "first": "Ada",
                "initial": "A.",
                "last": "Lam"
            },
            {
                "email": null,
                "first": "Nicolas",
                "initial": "N.",
                "last": "Laroudie"
            },
            {
                "email": null,
                "first": "Anilkumar",
                "initial": "A.",
                "last": "Kangokar"
            },
            {
                "email": null,
                "first": "Daniel",
                "initial": "D.",
                "last": "Wright"
            },
            {
                "email": null,
                "first": "George M.",
                "initial": "G.M.",
                "last": "Warimwe"
            },
            {
                "email": null,
                "first": "Phillip",
                "initial": "P.",
                "last": "Angell-Manning"
            },
            {
                "email": null,
                "first": "Adam J.",
                "initial": "A.J.",
                "last": "Ritchie"
            },
            {
                "email": null,
                "first": "Sarah C.",
                "initial": "S.C.",
                "last": "Gilbert"
            },
            {
                "email": null,
                "first": "Alex",
                "initial": "A.",
                "last": "Xenopoulos"
            },
            {
                "email": null,
                "first": "Anissa",
                "initial": "A.",
                "last": "Boumlic"
            },
            {
                "email": "sandy.douglas@ndm.ox.ac.uk",
                "first": "Alexander D.",
                "initial": "A.D.",
                "last": "Douglas"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.04.056",
        "firstpage": "6951",
        "issn": "0264410X",
        "keywords": [
            "Biomanufacturing",
            "Bioreactor",
            "Clinical trials",
            "GMP",
            "Purification",
            "Simian adenovirus",
            "Single-use"
        ],
        "lastpage": "6961",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components"
    }
}